{"claim": "SARS-CoV-2 binds ACE2 receptor to gain entry into cells", "claim_id": 0, "docs": {"221819877": {"label": "SUPPORT", "evidence": ["We find that the RBD of the spike protein of SARS-CoV-2 is highly optimized to achieve very strong binding with human ACE2 (hACE2) which is consistent with its enhanced infectivity."], "aliases": [], "pinfo": {"citationCount": 24, "influentialCitationCount": 1}, "ainfo": {"authors": ["6048696", "81508704", "2633265"], "numAuthors": 3, "maxPaperCount": 300, "medianPaperCount": 33, "maxCitationCount": 15934, "medianCitationCount": 427, "maxHIndex": 67, "medianHIndex": 13}, "rinfo": {"9714116": {"isInfluential": false, "contexts": ["Residue-level details about the interactions at the hACE2-ATR1 interface (both when RBD is bound or unbound to hACE2) and also at the hACE2-RBD interface, were informed using the Prodigy server [22] and have been listed in Supplementary Data 1."], "intents": ["methodology"]}, "215549013": {"isInfluential": false, "contexts": ["There have been several structural analyses [2,3] of both SARSCoV-1 and SARS-CoV-2 binding interactions with human ACE2 (hACE2) but no quantitative assessment of the contribution of different residues in the spike RBD towards tight binding or comparisons with its native receptor ATR1."], "intents": ["background"]}, "7245283": {"isInfluential": false, "contexts": [], "intents": []}, "24841346": {"isInfluential": false, "contexts": ["Similarly, unbound ATR1 structure (PDB: 4YAY [39]) was also separately downloaded and docked against hACE2 using protein\u2013protein docking scripts from Z-DOCK 3."], "intents": ["methodology"]}, "16728396": {"isInfluential": false, "contexts": ["However, in an uninfected cell, through the action of the renin angiotensin system (RAS), hACE2 forms a complex with the angiotensin 2 receptor type I (ATR1) [17]."], "intents": ["background"]}, "9938573": {"isInfluential": false, "contexts": [], "intents": []}, "14743508": {"isInfluential": false, "contexts": ["Deshotels et al.(18) and Lindrooth(19) report that hACE2 forms a complex with ATR1 based on co-immunoprecipitation experiments.", "Deshotels et al. [18] and Lindrooth [19] report that hACE2 forms a complex with ATR1 based on coimmunoprecipitation experiments."], "intents": ["background"]}, "214617869": {"isInfluential": true, "contexts": ["Note that Qiu et al. [29] used an ad hoc metric to rank animal ACE2 susceptibility as a proxy of interaction strengths with SARS-CoV-2 RBD.", "Our findings qualitatively agree with Qiu et al.(29) as both imply highest SARS-CoV-2 susceptibility to felines followed by canines.", "Note that Qiu et al.(29) used an ad hoc metric to rank animal ACE2 susceptibility as a proxy of interaction strengths with SARS-CoV-2 RBD.", "Our findings qualitatively agree with Qiu et al. [29] as both imply highest SARS-CoV-2 susceptibility to felines followed by canines."], "intents": ["result", "methodology"]}, "25775573": {"isInfluential": false, "contexts": [], "intents": []}, "211525070": {"isInfluential": false, "contexts": [], "intents": []}, "212418543": {"isInfluential": false, "contexts": ["[20]) where the RBD binding region of hACE2 is solvent exposed."], "intents": ["background"]}, "220979149": {"isInfluential": true, "contexts": ["Chan et al. [30] have reported all point mutations in the hACE2 that have been experimentally shown to enhance binding with SARS-CoV-2 RBD.", "We recovered 40 out of 77 binding improving single amino acid substitutions reported by Chan et al.(30) By exploring simultaneous mutations we identify two interface residues changes Phe32 and Ala36 which upon change (i.", "Chan et al.(30) have reported all point mutations in the hACE2 that have been experimentally shown to enhance binding with SARS-CoV-2 RBD.", "We recovered 40 out of 77 binding improving single amino acid substitutions reported by Chan et al. [30] By exploring simultaneous mutations we identify two interface residues changes Phe32 and Ala36 which upon change (i.e., F32A, F32E, A36E, and A36S) can establish electrostatic contacts with the RBD residue Gln493 (see Supplementary Fig."], "intents": ["background"]}, "218504900": {"isInfluential": false, "contexts": [], "intents": []}, "214802005": {"isInfluential": false, "contexts": [], "intents": []}, "228086824": {"isInfluential": false, "contexts": ["Experimental and computational investigations have focused on the RBD-hACE2 interaction for SARS-CoV-1 [5] and CoV-2 [7], the role of glycosylated spike residues [8], and the potential impact of the CoV-2\u2019s furin cleavage site [6]."], "intents": ["background"]}, "11306776": {"isInfluential": false, "contexts": [], "intents": []}, "219947290": {"isInfluential": false, "contexts": ["In another recent study [13], deep mutational scanning of SARS-CoV-2 RBD revealed that out of 21 interface residues, 18 residues upon substitution to alanine lead to a loss in binding affinity (10 of those leading to more than 50% loss in binding affinity) indicating that most interface amino acid changes are detrimental to ACE2 binding."], "intents": ["background"]}, "211253736": {"isInfluential": false, "contexts": [], "intents": []}, "2905074": {"isInfluential": false, "contexts": [], "intents": []}, "235689748": {"isInfluential": false, "contexts": [], "intents": []}, "214772541": {"isInfluential": false, "contexts": [], "intents": []}, "215551346": {"isInfluential": false, "contexts": [], "intents": []}, "770743": {"isInfluential": false, "contexts": [], "intents": []}, "52365003": {"isInfluential": false, "contexts": [], "intents": []}, "218976436": {"isInfluential": false, "contexts": [], "intents": []}, "216111282": {"isInfluential": false, "contexts": ["It has been suggested [2,4] that viral spike binding to hACE2 prevents ATR1 binding with hACE2 but no computational binding energy comparisons have been drawn."], "intents": ["background"]}, "5977701": {"isInfluential": false, "contexts": ["We computationally explored the potentially available margin of improvement for the binding affinity of SARS-CoV-2 with hACE2 using the IPRO [23,24] protein design software.", "We carried out a computational study using IPRO [23,24] to identify amino acid substitutions in the 30 hACE2 residues present at the hACE2-RBD binding interface that lead to enhanced RBD binding affinities (see Table 2)."], "intents": ["methodology"]}, "219605477": {"isInfluential": false, "contexts": [], "intents": []}, "230333589": {"isInfluential": false, "contexts": [], "intents": []}, "220304292": {"isInfluential": false, "contexts": [], "intents": []}, "14577343": {"isInfluential": true, "contexts": ["Finally, the SHAKE [50] algorithm was used to keep all bonds involving hydrogen atoms rigid.", "The default relaxation protocol of Desmond was performed followed by a 50 ns of production simulation at 1 atm pressure and 310 K temperature, using the NPT ensemble under a periodic boundary condition using particle mesh Ewald.", "MD simulations were performed using the Desmond [50] application (v2.", "Then, the membrane-bound structure was prepared using Desmond system builder."], "intents": ["methodology"]}, "4771915": {"isInfluential": false, "contexts": ["Rosetta binding energy calculations were performed by first running the relax application with the ref2015 [46] energy function and extracting binding energy (dG_binding) using the InterfaceAnalyzer [47] application."], "intents": ["methodology"]}, "219707256": {"isInfluential": false, "contexts": ["[36] recently reported that the amino acid substitution D614G leads to less S1 shedding and easier incorporation of S-protein into a pseudo-virion (retrovirus pseudo-typed with spike) leading to more efficient infection of hACE2-expressing cells.", "The prevalence of amino acid change D614G has been widely reported [35,36] to have increased from less 10% originally to over 95% in late spring of 2020 [37]."], "intents": ["background"]}, "220303111": {"isInfluential": false, "contexts": [], "intents": []}, "214734352": {"isInfluential": false, "contexts": ["It has been suggested [2,4] that viral spike binding to hACE2 prevents ATR1 binding with hACE2 but no computational binding energy comparisons have been drawn.", "There have been several structural analyses [2,3] of both SARSCoV-1 and SARS-CoV-2 binding interactions with human ACE2 (hACE2) but no quantitative assessment of the contribution of different residues in the spike RBD towards tight binding or comparisons with its native receptor ATR1."], "intents": ["background"]}, "40474743": {"isInfluential": false, "contexts": [], "intents": []}, "215741066": {"isInfluential": false, "contexts": [], "intents": []}, "212407874": {"isInfluential": false, "contexts": ["It has been reported that the first step to viral entry is association between the viral spike RBD and human ACE2 protein [1]."], "intents": ["background"]}, "212718418": {"isInfluential": true, "contexts": ["We ran 50 ns all-atom MD simulations with the membrane-bound conformation of hACE2 in complex with ATR1 first in the absence of viral spike RBD in the extracellular space, and next with the spike RBD bound to hACE2 as shown in Fang et al.(21) MD results suggest a lowering of hACE2-ATR1 complex stability by 44.", "We ran 50 ns all-atom MD simulations with the membrane-bound conformation of hACE2 in complex with ATR1 first in the absence of viral spike RBD in the extracellular space, and next with the spike RBD bound to hACE2 as shown in Fang et al. [21] MD results suggest a lowering of hACE2-ATR1 complex stability by 44.2% when RBD was bound to hACE2."], "intents": ["methodology"]}, "34228270": {"isInfluential": false, "contexts": [], "intents": []}, "21977664": {"isInfluential": false, "contexts": ["Experimental and computational investigations have focused on the RBD-hACE2 interaction for SARS-CoV-1 [5] and CoV-2 [7], the role of glycosylated spike residues [8], and the potential impact of the CoV-2\u2019s furin cleavage site [6]."], "intents": ["background"]}, "16715721": {"isInfluential": false, "contexts": [], "intents": []}, "210949404": {"isInfluential": false, "contexts": [], "intents": []}, "51971240": {"isInfluential": false, "contexts": ["We have used experimentally determined coordinates of SARSCoV-1 and SARS-CoV-2 in complex with ACE2 (PDB accessions: 6ACG [16] and 6LZG \u2013 www."], "intents": ["methodology"]}, "219398055": {"isInfluential": true, "contexts": ["[9] report Y440K, L455M, and Y505F to be the best point mutations at these loci.", "[9] in terms of the strengthening contribution to binding energy of each amino acid change separately.", "[9] where eight out of eleven of our predicted RBD single amino acid substitutions were shown to improve binding.", "[9] using all atom MD simulations showed that the SARS-CoV-2 RBD forms a more stable complex with hACE2 compared to SARS-CoV-1 by recruiting an enhanced hydrogen bonding network and greater electrostatic complementarity."], "intents": ["methodology", "background"]}, "206390967": {"isInfluential": false, "contexts": ["Rosetta binding energy calculations were performed by first running the relax application with the ref2015 [46] energy function and extracting binding energy (dG_binding) using the InterfaceAnalyzer [47] application."], "intents": ["methodology"]}, "206320185": {"isInfluential": false, "contexts": ["First, a fragment structure assembly was performed using replica-exchange Monte Carlo [43] followed by clustering of decoy ACE2 structures generated using the SPICKER protocol [44]."], "intents": ["methodology"]}, "221367384": {"isInfluential": false, "contexts": [], "intents": []}, "214763496": {"isInfluential": false, "contexts": ["Experimental and computational investigations have focused on the RBD-hACE2 interaction for SARS-CoV-1 [5] and CoV-2 [7], the role of glycosylated spike residues [8], and the potential impact of the CoV-2\u2019s furin cleavage site [6]."], "intents": ["background"]}, "13946752": {"isInfluential": false, "contexts": [], "intents": []}}, "publish_time": "2020-09-18", "journal": "Comput Struct Biotechnol J"}, "214793574": {"label": "SUPPORT", "evidence": ["SARS-CoV-2 is a novel highly virulent pathogen which gains entry to human cells by binding with the cell surface receptor - angiotensin converting enzyme (ACE2).", "We find that the RBD of the spike protein of SARS-CoV-2 is highly optimized to achieve very strong binding with human ACE2 (hACE2) which is consistent with its enhanced infectivity."], "aliases": [], "pinfo": {"citationCount": 17, "influentialCitationCount": 0}, "ainfo": {"authors": ["6048696", "2633265"], "numAuthors": 2, "maxPaperCount": 300, "medianPaperCount": 166.5, "maxCitationCount": 15934, "medianCitationCount": 8180.5, "maxHIndex": 67, "medianHIndex": 40.0}, "rinfo": {"215549013": {"contexts": [], "isInfluential": false, "intents": []}, "24841346": {"contexts": [], "isInfluential": false, "intents": []}, "16728396": {"contexts": [], "isInfluential": false, "intents": []}, "9938573": {"contexts": [], "isInfluential": false, "intents": []}, "25775573": {"contexts": [], "isInfluential": false, "intents": []}, "218530412": {"contexts": [], "isInfluential": false, "intents": []}, "211525070": {"contexts": [], "isInfluential": false, "intents": []}, "212418543": {"contexts": [], "isInfluential": false, "intents": []}, "2905074": {"contexts": [], "isInfluential": false, "intents": []}, "214772541": {"contexts": [], "isInfluential": false, "intents": []}, "215551346": {"contexts": [], "isInfluential": false, "intents": []}, "770743": {"contexts": [], "isInfluential": false, "intents": []}, "52365003": {"contexts": [], "isInfluential": false, "intents": []}, "212631502": {"contexts": [], "isInfluential": false, "intents": []}, "216111282": {"contexts": [], "isInfluential": false, "intents": []}, "5977701": {"contexts": [], "isInfluential": false, "intents": []}, "230333589": {"contexts": [], "isInfluential": false, "intents": []}, "89717906": {"contexts": [], "isInfluential": false, "intents": []}, "214734352": {"contexts": [], "isInfluential": false, "intents": []}, "40474743": {"contexts": [], "isInfluential": false, "intents": []}, "212407874": {"contexts": [], "isInfluential": false, "intents": []}, "21977664": {"contexts": [], "isInfluential": false, "intents": []}, "210949404": {"contexts": [], "isInfluential": false, "intents": []}, "51971240": {"contexts": ["Atomic coordinates of both these complexes were independently, and 197 experimentally confirmed by Song et al.(11) in 2018 and Wang et al.", "Atomic coordinates of both these complexes were independently, and experimentally confirmed by Song et al.11 in 2018 and Wang et al. in 2020 (manuscript unpublished but structure deposited at \u2013 www.rcsb.org/structure/6lzg)."], "isInfluential": false, "intents": ["methodology"]}, "173992314": {"contexts": [], "isInfluential": false, "intents": []}, "206320185": {"contexts": [], "isInfluential": false, "intents": []}, "214763496": {"contexts": [], "isInfluential": false, "intents": []}, "13946752": {"contexts": [], "isInfluential": false, "intents": []}}, "publish_time": "2020-05-11", "journal": "bioRxiv"}, "235628341": {"label": "SUPPORT", "evidence": ["Angiotensin converting enzyme 2 (ACE2) is the membrane-delimited receptor for SARS-CoV-2.", "Here, we report NHERF1 tethers ACE2 and augments SARS-CoV-2 cell entry.", "Ablating ACE2 interaction with NHERF1 accelerated SARS-CoV-2 cell entry.", "Conversely, elimination of the ACE2 C-terminal PDZ binding motif decreased ACE2 membrane residence and reduced pseudotyped virus entry."], "aliases": [], "pinfo": {"citationCount": 7, "influentialCitationCount": 0}, "ainfo": {"authors": ["11158410", "4668401", "144125561", "2291737", "153001242"], "numAuthors": 5, "maxPaperCount": 178, "medianPaperCount": 30, "maxCitationCount": 6233, "medianCitationCount": 412, "maxHIndex": 47, "medianHIndex": 12}, "rinfo": {"224823992": {"intents": [], "isInfluential": false, "contexts": []}, "8479578": {"intents": ["background"], "isInfluential": false, "contexts": ["Additionally, NHERF1 knockouts seem to have a far more impactful phenotype than other NHERF scaffold protein as reported in the regulation of the cystic fibrosis transmembrane conductance regulator (CFTR) by NHERF1 (Ardura and Friedman, 2011; Hynes, 2011; Jeong et al., 2019; Seidler et al., 2009; Singh et al., 2009; Wheeler et al., 2011).", "\u2026a far more impactful phenotype than other NHERF scaffold protein as reported in the regulation of the cystic fibrosis transmembrane conductance regulator (CFTR) by NHERF1 (Ardura and Friedman, 2011; Hynes, 2011; Jeong et al., 2019; Seidler et al., 2009; Singh et al., 2009; Wheeler et al., 2011)."]}, "222347383": {"intents": ["background"], "isInfluential": false, "contexts": ["Mature progeny virions are then formed and bud from plasma membranes by exocytosis (Harrison et al., 2020)."]}, "7298409": {"intents": ["background"], "isInfluential": false, "contexts": ["GPCR internalization associated with b-arrestins is mostly clathrin dependent (Gurevich and Gurevich, 2013).", "GPCR internalization associated with \u03b2-arrestins is mostly clathrindependent (Gurevich and Gurevich, 2013)."]}, "227942254": {"intents": ["background"], "isInfluential": false, "contexts": ["In addition, utilization of b-arrestin in SARS-CoV-2 entry may depress b-arrestin-mediated cell signaling and affect other b-arrestin-regulated biological processes (Ahn et al., 2020; Latorraca et al., 2020)."]}, "18730711": {"intents": [], "isInfluential": false, "contexts": []}, "206565323": {"intents": ["background"], "isInfluential": false, "contexts": ["ACE2 is not a classical membrane-spanning receptor such as the G protein-coupled receptors or receptor tyrosine kinases that transduce binding of an extracellular ligand to intracellular signals that trigger a cascade of biologically appropriate responses (Drake et al., 2006; Wacker et al., 2017)."]}, "221323900": {"intents": ["background"], "isInfluential": false, "contexts": ["Human and bat ACE2/Ace2 and NRP1/Nrp1 are used because they are primary hosts of SARS-CoV-2 (Burki, 2020)."]}, "13131970": {"intents": ["methodology"], "isInfluential": true, "contexts": ["The\niScience 24, 102770, July 23, 2021 15\nintegrated intensities for these two circled regions were employed as readouts (Platre et al., 2019) to quantify RFP immunofluorescence and measured using ImageJ (Schneider et al., 2012) as described previously (Boutte et al., 2013).", "(C) Quantification analysis of Figure 1B by ImageJ (Schneider et al., 2012).", "Experimental models: Cell lines\nCalu-3 (ATCC HTB-55TM) ATCC HTB-55 Caco-2 (ATCC HTB-37TM) ATCC HTB-37\nSoftware and algorithms\nPyMOL Schro\u0308dinger https://pymol.org/2/\nDomain Graph (DOG) Ren et al. (2009) http://dog.biocuckoo.org/\nImageJ Schneider et al. (2012) https://imagej.nih.gov/ij/\nGraphPad Prism 9 GraphPad https://www.graphpad.com/scientific-\nsoftware/prism/\nImaris software Oxford Instruments https://imaris.oxinst.com/", "Fluorescence intensity was quantified by ImageJ (Schneider et al., 2012)."]}, "205137023": {"intents": [], "isInfluential": false, "contexts": []}, "1214181": {"intents": ["background"], "isInfluential": false, "contexts": ["ACE2 is not a classical membrane-spanning receptor such as the G protein-coupled receptors or receptor tyrosine kinases that transduce binding of an extracellular ligand to intracellular signals that trigger a cascade of biologically appropriate responses (Drake et al., 2006; Wacker et al., 2017)."]}, "3300518": {"intents": ["background"], "isInfluential": false, "contexts": ["These sites may mediate SARS-CoV-2 receptor binding to b-arrestin as in the case of b2AR, where the phosphorylated receptor C terminus is required for binding to b-arrestin and receptor internalization (Nobles et al., 2011).", "These sites may mediate SARSCoV-2 receptor binding to \u03b2-arrestin as in the case of \u03b22AR, where the phosphorylated receptor C-terminus is required for binding to \u03b2-arrestin and receptor internalization (Nobles et al., 2011)."]}, "221472682": {"intents": ["background"], "isInfluential": false, "contexts": ["b-Arrestins control a variety of cellular activities ranging from cytoskeletal rearrangement to transcriptional regulation, cell growth and survival, and GPCR endocytosis, trafficking and GPCR signaling (Ahn et al., 2020).", "In addition, utilization of b-arrestin in SARS-CoV-2 entry may depress b-arrestin-mediated cell signaling and affect other b-arrestin-regulated biological processes (Ahn et al., 2020; Latorraca et al., 2020)."]}, "212418543": {"intents": [], "isInfluential": false, "contexts": []}, "35830953": {"intents": ["background", "result"], "isInfluential": false, "contexts": ["BAT1 membrane trafficking and coordinates peptide digestion and neutral amino acid uptake in the intestine and kidney (Kowalczuk et al., 2008).", "In addition to NHERF1 and b-arrestin, BAT1 with ACE2 as mentioned above is also found in kidney HK2 cells used in Figure 4B and co-immunoprecipitates with myc-ACE2 at endogenous expression levels (Figure S5) as reported (Kowalczuk et al., 2008)."]}, "81728704": {"intents": ["methodology"], "isInfluential": false, "contexts": ["To authenticate that this interaction occurs at endogenous levels in SARS-CoV-2-favored tissues lung and intestine (Gupta et al., 2020), proximity ligation assays (PLAs) were applied to characterize ACE2 interactions with NHERF1 in human Calu-3 pulmonary epithelial cells and Caco-2 intestinal\u2026", "To authenticate that this interaction occurs at endogenous levels in SARS-CoV-2-favored tissues lung and intestine (Gupta et al., 2020), proximity ligation assays (PLA) were applied to characterize ACE2 interactions with NHERF1 in human Calu-3 pulmonary epithelial cells and Caco-2 intestinal enterocytes."]}, "220979149": {"intents": [], "isInfluential": false, "contexts": []}, "73413166": {"intents": [], "isInfluential": false, "contexts": []}, "38173512": {"intents": ["background"], "isInfluential": true, "contexts": ["Thus, NHERF1\niScience 24, 102770, July 23, 2021 9\nregulates ACE2-mediated SARS-CoV-2 cell entry, possibly through a mechanism controlling the kinetics of ACE2 internalization as with the P2Y12 receptor (Nisar et al., 2012).", "In the caseof theGprotein-coupledpurinergic receptor (P2Y12R), bothb-arrestin andNHERF1 support efficient receptor internalization,where thepresenceof an intact PDZ-bindingmotif is required to form the b-arrestin-NHERF1-receptor complex (Nisar et al., 2012).", "NHERF1 facilitates internalization of the G protein-coupled P2Y12 and parathyroid hormone receptors (Nisar et al., 2012; Wang et al., 2009) by promoting association with b-arrestin adapter proteins. b-Arrestins, which are commonly required for GPCR internalization (Ferguson et al., 1996), interact\u2026", "PDZ interactions formed by NHERF1 and ACE2 may play a central role in tethering this super-complex to facilitate ACE2 receptor internalization as observed for the ternary complex b-arrestin-NHERF1-P2Y12R (Nisar et al., 2012)."]}, "220672111": {"intents": [], "isInfluential": false, "contexts": []}, "4423127": {"intents": ["background", "methodology"], "isInfluential": false, "contexts": ["(F) Computational modeling of NHERF1 PDZ1 (red) or PDZ2 (green) structure complexed with the C-terminal eight-residue tail of ACE2 by molecular dynamics simulation as detailed previously (Mamonova et al., 2015).", "\u2026from the PDZ1-preferred binding exhibited by the type 2 sodium phosphate cotransporter (NPT2A), where despite the above-mentioned identical hydrogen bonds, the PDZ-binding motif 636ATRL639 forms an extra-strong Arg-1/Glu43 salt bridge (Mamonova et al., 2015) that is absent in the second PDZ domain.", "The equivalent hydrogen bond interactions observed in PDZ1 and PDZ2 explain why ACE2 binds comparably with either PDZ domain of NHERF1, notably different from the PDZ1-preferred binding exhibited by the type 2 sodium phosphate cotransporter (NPT2A), where despite the above-mentioned identical hydrogen bonds, the PDZ-binding motif (636)ATRL(639) forms an extra-strong Arg-1/Glu(43) salt bridge (Mamonova et al., 2015) that is absent in the second PDZ domain."]}, "219604383": {"intents": [], "isInfluential": false, "contexts": []}, "7980247": {"intents": ["methodology"], "isInfluential": false, "contexts": ["The boxed blots in red are from SDS-PAGE (Top panel) and the blots in the lower panel are from blue native PAGE performed as described before (Dewson, 2015)."]}, "199518746": {"intents": ["background"], "isInfluential": false, "contexts": ["\u2026process hijacks the host cell\u2019s endocytic machinery and specifically impairs b-arrestin-dependent GPCR internalization as implicated in the b2-adrenergic receptor (b2AR) (Ferguson et al., 1996) and calcium-sensing receptor (CaSR) (Mos et al., 2019) and, as a consequence, diverse GPCR signaling."]}, "212712753": {"intents": ["background"], "isInfluential": false, "contexts": ["Once internalized, SARS-CoV-2 may be transported to lysosomes for degradation (Yang and Shen, 2020) or in most cases escape endo-lysosomes to release its RNA genome to the cytosol."]}, "9181961": {"intents": ["background"], "isInfluential": false, "contexts": ["ACE2 is distributed ubiquitously in diverse cells particularly those such as pulmonary epithelial cells and intestinal enterocytes (Hamming et al., 2004) that are exposed to the external environments and serves as the SARS-CoV-2 receptor for binding to viral spike protein (Hoffmann et al."]}, "4083854": {"intents": ["methodology"], "isInfluential": false, "contexts": ["Experimental models: Cell lines\nCalu-3 (ATCC HTB-55TM) ATCC HTB-55 Caco-2 (ATCC HTB-37TM) ATCC HTB-37\nSoftware and algorithms\nPyMOL Schro\u0308dinger https://pymol.org/2/\nDomain Graph (DOG) Ren et al. (2009) http://dog.biocuckoo.org/\nImageJ Schneider et al. (2012) https://imagej.nih.gov/ij/\nGraphPad Prism 9 GraphPad https://www.graphpad.com/scientific-\nsoftware/prism/\nImaris software Oxford Instruments https://imaris.oxinst.com/", "The schematic diagram of NHERF1 was created by Domain Graph (DOG) (Ren et al., 2009).", "\u2026(ATCC HTB-55TM) ATCC HTB-55 Caco-2 (ATCC HTB-37TM) ATCC HTB-37\nSoftware and algorithms\nPyMOL Schro\u0308dinger https://pymol.org/2/\nDomain Graph (DOG) Ren et al. (2009) http://dog.biocuckoo.org/\nImageJ Schneider et al. (2012) https://imagej.nih.gov/ij/\nGraphPad Prism 9 GraphPad\u2026"]}, "220462000": {"intents": ["background"], "isInfluential": false, "contexts": ["GPCR internalization associated with b-arrestins is mostly clathrin dependent (Gurevich and Gurevich, 2013)."]}, "39977117": {"intents": [], "isInfluential": false, "contexts": []}, "9729847": {"intents": [], "isInfluential": false, "contexts": ["To verify ACE2 binding to NHERF1 and identify the required structural determinants for each, myc-ACE2 was coexpressed in the high-protein yield-generating HEK293 GnTI cells (Chaudhary et al., 2012) with wild-type Flag-NHERF1 or its various mutants wherein PDZ1 (S1) or PDZ2 (S2) was scrambled (GYGF \u2192 GAGA) (Figure 1B)."]}, "219604114": {"intents": [], "isInfluential": false, "contexts": []}, "224827310": {"intents": [], "isInfluential": false, "contexts": []}, "3349470": {"intents": [], "isInfluential": false, "contexts": []}, "218534865": {"intents": ["background"], "isInfluential": false, "contexts": [", 2004) that are exposed to the external environments and serves as the SARS-CoV-2 receptor for binding to viral spike protein (Hoffmann et al., 2020; Li et al., 2003; Shang et al., 2020)."]}, "11907256": {"intents": ["background"], "isInfluential": false, "contexts": ["ACE2 is a carboxypeptidase, primarily metabolizing angiotensin II (Ang II) to a heptapeptide Ang-(1-7) that contributes to the cardiorenal control of blood pressure (Ferrario et al., 2010)."]}, "231653951": {"intents": [], "isInfluential": false, "contexts": []}, "233291188": {"intents": [], "isInfluential": false, "contexts": []}, "36941407": {"intents": [], "isInfluential": false, "contexts": []}, "6915374": {"intents": ["background"], "isInfluential": false, "contexts": ["NHERF1 impacts sequestration of various receptors, particularly GPCRs (Weinman et al., 2006).", "This would explain why COVID-19 patients lose their sense of taste or smell mediated by specific taste or olfactory GPCRs, in addition to the reported hyperinflammatory response (Merad and Martin, 2020), where replication of SARS-CoV-2 induces cellular stress challenges."]}, "231588407": {"intents": [], "isInfluential": false, "contexts": []}, "24000289": {"intents": [], "isInfluential": false, "contexts": []}, "220602922": {"intents": [], "isInfluential": false, "contexts": []}, "31270115": {"intents": ["background"], "isInfluential": false, "contexts": ["\u2026a far more impactful phenotype than other NHERF scaffold protein as reported in the regulation of the cystic fibrosis transmembrane conductance regulator (CFTR) by NHERF1 (Ardura and Friedman, 2011; Hynes, 2011; Jeong et al., 2019; Seidler et al., 2009; Singh et al., 2009; Wheeler et al., 2011)."]}, "221011422": {"intents": [], "isInfluential": false, "contexts": []}, "16599724": {"intents": [], "isInfluential": false, "contexts": []}, "12619962": {"intents": [], "isInfluential": false, "contexts": []}, "212407874": {"intents": ["background"], "isInfluential": false, "contexts": ["Most attention has focused on the extracellular multi-step coordinated actions during virus entry involving the viral spike protein and host cell surface proteins angiotensin converting enzyme 2 (ACE2), TMPRSS2, and ADAM17 (Heurich et al., 2014; Hoffmann et al., 2020).", "Most attention has focussed on the extracellular multi-step coordinated actions during virus entry involving the viral spike protein and host cell surface proteins ACE2, TMPRSS2 and ADAM17 (Heurich et al., 2014; Hoffmann et al., 2020).", ", 2004) that are exposed to the external environments and serves as the SARS-CoV-2 receptor for binding to viral spike protein (Hoffmann et al., 2020; Li et al., 2003; Shang et al., 2020)."]}, "30639387": {"intents": [], "isInfluential": false, "contexts": []}, "52308369": {"intents": [], "isInfluential": false, "contexts": []}, "218512819": {"intents": [], "isInfluential": false, "contexts": []}, "205264069": {"intents": ["methodology"], "isInfluential": false, "contexts": ["The\niScience 24, 102770, July 23, 2021 15\nintegrated intensities for these two circled regions were employed as readouts (Platre et al., 2019) to quantify RFP immunofluorescence and measured using ImageJ (Schneider et al., 2012) as described previously (Boutte et al., 2013).", "Plasma membrane fluorescence intensity was obtained by subtracting the cytosolic signal from the total fluorescence measured in a single cell (Boutte et al., 2013; Platre et al., 2019)."]}, "96434580": {"intents": [], "isInfluential": false, "contexts": []}, "1430498": {"intents": [], "isInfluential": false, "contexts": []}, "12788411": {"intents": [], "isInfluential": false, "contexts": []}, "10212973": {"intents": ["background"], "isInfluential": false, "contexts": ["NHERF1 facilitates internalization of the G protein-coupled P2Y12 and parathyroid hormone receptors (Nisar et al., 2012; Wang et al., 2009) by promoting association with b-arrestin adapter proteins."]}, "34770935": {"intents": [], "isInfluential": false, "contexts": []}, "26835642": {"intents": ["methodology"], "isInfluential": false, "contexts": ["Experimental models: Cell lines\nCalu-3 (ATCC HTB-55TM) ATCC HTB-55 Caco-2 (ATCC HTB-37TM) ATCC HTB-37\nSoftware and algorithms\nPyMOL Schro\u0308dinger https://pymol.org/2/\nDomain Graph (DOG) Ren et al. (2009) http://dog.biocuckoo.org/\nImageJ Schneider et al. (2012) https://imagej.nih.gov/ij/\nGraphPad Prism 9 GraphPad https://www.graphpad.com/scientific-\nsoftware/prism/\nImaris software Oxford Instruments https://imaris.oxinst.com/", "The schematic diagram of NHERF1 was created by Domain Graph (DOG) (Ren et al., 2009)."]}}, "publish_time": "2021-01-01", "journal": "iScience"}, "214054683": {"label": "SUPPORT", "evidence": ["We show here that SARS-CoV-2 S mediates entry in VeroE6 cells and in BHK cells transiently transfected with human ACE2, establishing ACE2 as a functional receptor for this novel coronavirus.", "We further demonstrate that the receptor-binding domains of SARS-CoV-2 S and SARS-CoV S bind with similar affinities to human ACE2, which correlates with the efficient spread of SARS-CoV-2 among humans."], "aliases": [], "pinfo": {"citationCount": 663, "influentialCitationCount": 20}, "ainfo": {"authors": ["6771654", "49819280", "38645606", "48488732", "5171932", "6785017"], "numAuthors": 6, "maxPaperCount": 254, "medianPaperCount": 82.5, "maxCitationCount": 18938, "medianCitationCount": 10614.0, "maxHIndex": 57, "medianHIndex": 32.0}, "rinfo": {"7316989": {"intents": [], "contexts": [], "isInfluential": false}, "12623609": {"intents": ["background"], "contexts": ["For all CoVs, S is further cleaved by host proteases at the so-called S2\u2019 site located immediately upstream of the fusion peptide (Madu et al., 2009; Millet and Whittaker, 2015).", "\u2026studies also showed that the host proteases cathepsin L and TMPRSS2 prime SARS-CoV S for membrane fusion through cleavage at the S1/S2 and at the S2\u2019 sites (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "Previous studies also showed that the host proteases cathepsin L and TMPRSS2 prime SARS-CoV S for membrane fusion through cleavage at the S1/S2 and at the S2\u2019 sites (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "This cleavage has been proposed to activate the protein for membrane fusion via extensive irreversible conformational changes (Belouzard et al., 2009; Heald-Sargent and Gallagher, 2012; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2017b).", "in the fusion glycoprotein of SARS-CoV-2 could putatively expand its tropism and/or enhance its transmissibility, compared to SARS-CoV and SARSr-CoV isolates, due to the near-ubiquitous distribution of furin-like proteases and their reported effects on other viruses (Klenk and Garten, 1994; Millet and Whittaker, 2015; Steinhauer, 1999) .", "\u2026CoVs, S is cleaved at the boundary between the S1 and S2 subunits which remain non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 2003; Burkard et al., 2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2016a).", "\u2026cleavage site sets SARS-CoV-2 S apart from SARS-CoV S (and SARSr-CoV S) that possesses a monobasic S1/S2 cleavage site processed upon entry of target cells (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "The presence of a furin cleavage site sets SARS-CoV-2 S apart from SARS-CoV S (and SARSr-CoV S) that possesses a monobasic S1/S2 cleavage site processed upon entry of target cells (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "Besides binding to host cell receptors, priming of the S glycoprotein by host proteases through cleavage at the S1/S2 and the S2\u2019 sites is another crucial factor modulating tropism and pathogenicity (Millet and Whittaker, 2015).", "\u2026could putatively expand its tropism and/or enhance its transmissibility, compared to SARS-CoV and SARSr-CoV isolates, due to the near-ubiquitous distribution of furin-like proteases and their reported effects on other viruses (Klenk and Garten, 1994; Millet and Whittaker, 2015; Steinhauer, 1999)."], "isInfluential": true}, "22990727": {"intents": ["background"], "contexts": ["\u2026affinity of SARS-CoV for hACE2 with the rate of transmissibility, viral replication in distinct species and disease severity (Guan et al., 2003; Li et al., 2004; Li et al., 2005c; Wan et al., 2020), we hypothesize that the most pathogenic coronaviruses will exhibit S glycoprotein trimers\u2026", "SARS-CoV-2 recognizes human ACE2 with comparable affinity than SARS-CoV The binding affinity of SARS-CoV for hACE2 correlate with the overall rate of viral replication in distinct species, transmissibility and disease severity (Guan et al., 2003; Li et al., 2004; Li et al., 2005c; Wan et al., 2020).", "Moreover, the ability to engage ACE2 from different animal species appears to reflect host susceptibility to SARS-CoV infection and facilitated the jump of the virus from animals to humans (Li, 2008; Li et al., 2004)."], "isInfluential": false}, "15058951": {"intents": ["background"], "contexts": ["Whereas palm civets and racoon dogs have been recognized as an intermediate host for zoonotic transmission of SARS-CoV between bats and humans (Guan et al., 2003; Kan et al., 2005; Wang et al., 2005), the intermediate host of SARS-CoV-2 remains unknown."], "isInfluential": false}, "4878146": {"intents": [], "contexts": [], "isInfluential": false}, "19028284": {"intents": ["background"], "contexts": ["MERS-CoV was suggested to originate from bats but the reservoir host fueling spillover to humans is unequivocally dromedary camels (Haagmans et al., 2014; Memish et al., 2013)."], "isInfluential": false}, "53238075": {"intents": ["methodology"], "contexts": ["8 \u030a with local search for 25 iterations) were carried out using Relion (Zivanov et al., 2018) without imposing symmetry to separate distinct SARS-CoV-2 S conformations."], "isInfluential": false}, "10608627": {"intents": [], "contexts": [], "isInfluential": false}, "72334432": {"intents": ["background"], "contexts": ["These oligosaccharides participate in S folding (Rossen et al., 1998), they affect priming by host proteases (Yang et al., 2015b) and modulate antibody recognition (Pallesen et al., 2017; Walls et al., 2019).", "\u2026collection and refinement statistics Overall, the SARS-CoV-2 S ectodomain is a 160\u00c5-long trimer with a triangular crosssection, resembling the closely related SARS-CoV S structure (Fig S3 A-F)(Gui et al., 2017; Kirchdoerfer et al., 2018; Song et al., 2018; Walls et al., 2019; Yuan et al., 2017).", "\u2026rare memory B cells of individuals infected with SARS-CoV (Traggiai et al., 2004) or MERS-CoV (Corti et al., 2015) in complex with SARS-CoV S and MERS-CoV S to provide molecular-level information of the mechanism of competitive inhibition of SB attachment to the host receptor (Walls et al., 2019).", "The S230 anti-SARS-CoV antibody also acted by functionally mimicking receptor-attachment and promoting spike fusogenic conformational rearrangements through a ratcheting mechanism that elucidated the unique nature of the coronavirus membrane fusion activation (Walls et al., 2019).", "We note that most SARS-CoV neutralizing Abs isolated to date target the SB domain and several of them recognize the RBM and prevent receptor engagement (Hwang et al., 2006; Rockx et al., 2008; Rockx et al., 2010; Traggiai et al., 2004; Walls et al., 2019).", "\u2026cell surface and initiating the conformational changes leading to cleavage of the S2\u2019 site, membrane fusion and viral entry (Gui et al., 2017; Kirchdoerfer et al., 2018; Millet and Whittaker, 2014; Pallesen et al., 2017; Park et al., 2016; Song et al., 2018; Walls et al., 2019; Yuan et al., 2017).", "\u2026cross-react and neutralize the two viruses as well as related coronaviruses (Fig S3 G-H) We previously showed that coronavirus S glycoproteins are densely decorated by heterogeneous N-linked glycans protruding from the trimer surface (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017).", "By comparison, SARS-CoV S possesses 23 N-linked glycosylation sequons per protomer and we previously confirmed experimentally that at least 19 of them are glycosylated (Walls et al., 2019).", "\u2026including SARS-CoV S (Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Park et al., 2019; Song et al., 2018; Tortorici et al., 2019; Walls et al., 2016a; Walls et al., 2016b; Walls et al., 2019; Yuan et al., 2017), the S1 subunit has a V-shaped architecture (Fig S3 B-E).", "S trimers are extensively decorated with N-linked glycans that are important for proper folding (Rossen et al., 1998) and to modulate accessibility to host proteases and neutralizing antibodies (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017; Yang et al., 2015b).", "\u2026ectodomain trimer construct with an abrogated furin S1/S2 cleavage site (Tortorici et al., 2019; Walls et al., 2017a; Walls et al., 2016a; Walls et al., 2019), two consecutive proline stabilizing mutations (Kirchdoerfer et al., 2018; Pallesen et al., 2017) and a C-terminal foldon\u2026", "Similarly to SARS-CoV S and MERS-CoV S (Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Song et al., 2018; Walls et al., 2019; Yuan et al., 2017), we found that the SARS-CoV-2 S trimer exist in multiple, distinct conformational states resulting from SB opening at the trimer apex.", "\u2026MERS-CoV S trimers although we did not detect trimers with two SB domains open and the distribution of particles across the S conformational landscape varies among studies (Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Song et al., 2018; Walls et al., 2019; Yuan et al., 2017).", "We previously suggested coronaviruses use conformational masking and glycan shielding to limit recognition by the immune response of infected hosts (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017).", "These structural changes are necessary for receptor engagement of these three viruses and lead to initiation of fusogenic conformational changes (Song et al., 2018; Walls et al., 2017b; Walls et al., 2019)."], "isInfluential": false}, "25154538": {"intents": ["background"], "contexts": ["For instance, entry of the MERS-CoV-related bat coronavirus HKU4 into human cells required addition of exogenous trypsin, indicating that S proteolytic activation of this bat virus did not occur in human cells (despite its ability to recognize human DPP4)(Wang et al., 2014; Yang et al., 2014)."], "isInfluential": false}, "25655996": {"intents": ["background"], "contexts": ["\u2026a prefusion stabilized ectodomain trimer construct with an abrogated furin S1/S2 cleavage site (Tortorici et al., 2019; Walls et al., 2017a; Walls et al., 2016a; Walls et al., 2019), two consecutive proline stabilizing mutations (Kirchdoerfer et al., 2018; Pallesen et al., 2017) and a\u2026", "As HCoV-NL63 and HCoV-229E are known to engage protein receptors through SB (Wong et al., 2017; Wu et al., 2009), trimer opening is also expected to occur to expose their receptor-recognition motifs that are otherwise buried at the interface between protomers in the closed S trimer (Li et al., 2019; Walls et al., 2016b).", "\u2026are known to engage protein receptors through SB (Wong et al., 2017; Wu et al., 2009), trimer opening is also expected to occur to expose their receptor-recognition motifs that are otherwise buried at the interface between protomers in the closed S trimer (Li et al., 2019; Walls et al., 2016b).", "\u2026CoVs, S is cleaved at the boundary between the S1 and S2 subunits which remain non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 2003; Burkard et al., 2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2016a).", "\u2026cross-react and neutralize the two viruses as well as related coronaviruses (Fig S3 G-H) We previously showed that coronavirus S glycoproteins are densely decorated by heterogeneous N-linked glycans protruding from the trimer surface (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017).", "\u2026domain(s), and contributes to stabilization of the prefusion state of the membrane-anchored S2 subunit that contains the fusion machinery (Gui et al., 2017; Kirchdoerfer et al., 2016; Pallesen et al., 2017; Song et al., 2018; Walls et al., 2016a; Walls et al., 2017b; Yuan et al., 2017).", "\u2026including SARS-CoV S (Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Park et al., 2019; Song et al., 2018; Tortorici et al., 2019; Walls et al., 2016a; Walls et al., 2016b; Walls et al., 2019; Yuan et al., 2017), the S1 subunit has a V-shaped architecture (Fig S3 B-E).", "S trimers are extensively decorated with N-linked glycans that are important for proper folding (Rossen et al., 1998) and to modulate accessibility to host proteases and neutralizing antibodies (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017; Yang et al., 2015b).", "In addition to the highly pathogenic zoonotic pathogens SARS-CoV, MERS-CoV and SARS-CoV-2, all belonging to the \u03b2-coronavirus genus, four low pathogenicity coronaviruses are endemic in humans: HCoV-OC43, HCoV-HKU1, HCoV-NL63 and HCoV-229E.", "In contrast, only closed S trimers have been detected for HCoV-NL63 (Walls et al., 2016b), HCoV-OC43 (Tortorici et al., 2019), HCoV-HKU1 (Kirchdoerfer et al., 2016) and HCoV-229E (Li et al., 2019).", "We previously suggested coronaviruses use conformational masking and glycan shielding to limit recognition by the immune response of infected hosts (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017)."], "isInfluential": false}, "34362619": {"intents": ["background"], "contexts": ["MERS-CoV was suggested to originate from bats but the reservoir host fueling spillover to humans is unequivocally dromedary camels (Haagmans et al., 2014; Memish et al., 2013)."], "isInfluential": false}, "40873943": {"intents": ["methodology"], "contexts": ["Data were acquired using the Leginon software (Suloway et al., 2005) to control an FEI Titan Krios transmission electron microscope operated at 300 kV and equipped with a Gatan K2 Summit direct detector and Gatan Quantum GIF energy filter, operated in zero-loss mode with a slit width of 20 eV."], "isInfluential": false}, "4449877": {"intents": ["background"], "contexts": ["\u2026a prefusion stabilized ectodomain trimer construct with an abrogated furin S1/S2 cleavage site (Tortorici et al., 2019; Walls et al., 2017a; Walls et al., 2016a; Walls et al., 2019), two consecutive proline stabilizing mutations (Kirchdoerfer et al., 2018; Pallesen et al., 2017) and a\u2026", "As HCoV-NL63 and HCoV-229E are known to engage protein receptors through SB (Wong et al., 2017; Wu et al., 2009), trimer opening is also expected to occur to expose their receptor-recognition motifs that are otherwise buried at the interface between protomers in the closed S trimer (Li et al., 2019; Walls et al., 2016b).", "\u2026are known to engage protein receptors through SB (Wong et al., 2017; Wu et al., 2009), trimer opening is also expected to occur to expose their receptor-recognition motifs that are otherwise buried at the interface between protomers in the closed S trimer (Li et al., 2019; Walls et al., 2016b).", "\u2026CoVs, S is cleaved at the boundary between the S1 and S2 subunits which remain non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 2003; Burkard et al., 2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2016a).", "\u2026cross-react and neutralize the two viruses as well as related coronaviruses (Fig S3 G-H) We previously showed that coronavirus S glycoproteins are densely decorated by heterogeneous N-linked glycans protruding from the trimer surface (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017).", "\u2026domain(s), and contributes to stabilization of the prefusion state of the membrane-anchored S2 subunit that contains the fusion machinery (Gui et al., 2017; Kirchdoerfer et al., 2016; Pallesen et al., 2017; Song et al., 2018; Walls et al., 2016a; Walls et al., 2017b; Yuan et al., 2017).", "\u2026including SARS-CoV S (Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Park et al., 2019; Song et al., 2018; Tortorici et al., 2019; Walls et al., 2016a; Walls et al., 2016b; Walls et al., 2019; Yuan et al., 2017), the S1 subunit has a V-shaped architecture (Fig S3 B-E).", "S trimers are extensively decorated with N-linked glycans that are important for proper folding (Rossen et al., 1998) and to modulate accessibility to host proteases and neutralizing antibodies (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017; Yang et al., 2015b).", "In addition to the highly pathogenic zoonotic pathogens SARS-CoV, MERS-CoV and SARS-CoV-2, all belonging to the \u03b2-coronavirus genus, four low pathogenicity coronaviruses are endemic in humans: HCoV-OC43, HCoV-HKU1, HCoV-NL63 and HCoV-229E.", "In contrast, only closed S trimers have been detected for HCoV-NL63 (Walls et al., 2016b), HCoV-OC43 (Tortorici et al., 2019), HCoV-HKU1 (Kirchdoerfer et al., 2016) and HCoV-229E (Li et al., 2019).", "We previously suggested coronaviruses use conformational masking and glycan shielding to limit recognition by the immune response of infected hosts (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017)."], "isInfluential": false}, "21887896": {"intents": ["background"], "contexts": ["\u2026cleavage site sets SARS-CoV-2 S apart from SARS-CoV S (and SARSr-CoV S) that possesses a monobasic S1/S2 cleavage site processed upon entry of target cells (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "The presence of a furin cleavage site sets SARS-CoV-2 S apart from SARS-CoV S (and SARSr-CoV S) that possesses a monobasic S1/S2 cleavage site processed upon entry of target cells (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "Previous studies also showed that the host proteases cathepsin L and TMPRSS2 prime SARS-CoV S for membrane fusion through cleavage at the S1/S2 and at the S2\u2019 sites (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "\u2026studies also showed that the host proteases cathepsin L and TMPRSS2 prime SARS-CoV S for membrane fusion through cleavage at the S1/S2 and at the S2\u2019 sites (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011)."], "isInfluential": true}, "5795468": {"intents": ["background"], "contexts": ["For all CoVs, S is further cleaved by host proteases at the so-called S2\u2019 site located immediately upstream of the fusion peptide (Madu et al., 2009; Millet and Whittaker, 2015).", "\u2026studies also showed that the host proteases cathepsin L and TMPRSS2 prime SARS-CoV S for membrane fusion through cleavage at the S1/S2 and at the S2\u2019 sites (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "This cleavage has been proposed to activate the protein for membrane fusion via extensive irreversible conformational changes (Belouzard et al., 2009; Heald-Sargent and Gallagher, 2012; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2017b).", "\u2026CoVs, S is cleaved at the boundary between the S1 and S2 subunits which remain non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 2003; Burkard et al., 2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2016a).", "\u2026cleavage site sets SARS-CoV-2 S apart from SARS-CoV S (and SARSr-CoV S) that possesses a monobasic S1/S2 cleavage site processed upon entry of target cells (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "Besides binding to host cell receptors, priming of the S glycoprotein by host proteases through cleavage at the S1/S2 and the S2\u2019 sites is another crucial factor modulating tropism and pathogenicity (Millet and Whittaker, 2015).", "\u2026could putatively expand its tropism and/or enhance its transmissibility, compared to SARS-CoV and SARSr-CoV isolates, due to the near-ubiquitous distribution of furin-like proteases and their reported effects on other viruses (Klenk and Garten, 1994; Millet and Whittaker, 2015; Steinhauer, 1999)."], "isInfluential": true}, "35638983": {"intents": ["background"], "contexts": ["We note that most SARS-CoV neutralizing Abs isolated to date target the SB domain and several of them recognize the RBM and prevent receptor engagement (Hwang et al., 2006; Rockx et al., 2008; Rockx et al., 2010; Traggiai et al., 2004; Walls et al., 2019)."], "isInfluential": false}, "4917822": {"intents": ["background"], "contexts": ["Regardless of the nature of the receptor and of the location of the receptor-binding domains, removal of the trimeric S1 crown is expected to be necessary for all coronaviruses to allow the large-scale S2 conformational changes leading to fusion of the viral and host membranes (Walls et al., 2017b).", "This cleavage has been proposed to activate the protein for membrane fusion via extensive irreversible conformational changes (Belouzard et al., 2009; Heald-Sargent and Gallagher, 2012; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2017b).", "\u2026S glycoprotein, we designed a prefusion stabilized ectodomain trimer construct with an abrogated furin S1/S2 cleavage site (Tortorici et al., 2019; Walls et al., 2017a; Walls et al., 2016a; Walls et al., 2019), two consecutive proline stabilizing mutations (Kirchdoerfer et al., 2018; Pallesen et\u2026", "\u2026domain(s), and contributes to stabilization of the prefusion state of the membrane-anchored S2 subunit that contains the fusion machinery (Gui et al., 2017; Kirchdoerfer et al., 2016; Pallesen et al., 2017; Song et al., 2018; Walls et al., 2016a; Walls et al., 2017b; Yuan et al., 2017).", "These structural changes are necessary for receptor engagement of these three viruses and lead to initiation of fusogenic conformational changes (Song et al., 2018; Walls et al., 2017b; Walls et al., 2019)."], "isInfluential": false}, "22885598": {"intents": [], "contexts": [], "isInfluential": false}, "208539816": {"intents": ["background"], "contexts": ["As is the case for other \u03b2-coronavirus S glycoproteins, including SARS-CoV S (Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Park et al., 2019; Song et al., 2018; Tortorici et al., 2019; Walls et al., 2016a; Walls et al., 2016b; Walls et al., 2019; Yuan et al., 2017), the S1\u2026", "MERS-CoV S, however, uses domain A to engage non-acetylated sialosides as attachment receptors (Li et al., 2017; Park et al., 2019) and promote subsequent binding of domain B (S) to the entry receptor, dipeptidyl-peptidase 4 (Lu et al.", "(Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Park et al., 2019; Song et al., 2018; Tortorici et al., 2019; Walls et al., 2016a; Walls et al., 2016b; Walls et al., 2019; Yuan et al., 2017), the S1 subunit has a V-shaped architecture (Fig S3 B-E).", "MERS-CoV S, however, uses domain A to engage non-acetylated sialosides as attachment receptors (Li et al., 2017; Park et al., 2019) and promote subsequent binding of domain B (SB) to the entry receptor, dipeptidyl-peptidase 4 (Lu et al., 2013; Raj et al., 2013)."], "isInfluential": false}, "28235502": {"intents": ["background"], "contexts": ["Whereas palm civets and racoon dogs have been recognized as an intermediate host for zoonotic transmission of SARS-CoV between bats and humans (Guan et al., 2003; Kan et al., 2005; Wang et al., 2005), the intermediate host of SARS-CoV-2 remains unknown.", "Indeed, SARS-CoV isolates from the three phases of the 2002-2003 epidemic were more efficiently transmitted among humans and more pathogenic than the isolates associated with the 2003-2004 re-emergence that caused only a few cases, in line with their binding affinities for hACE2 (Consortium, 2004; Kan et al., 2005; Li et al., 2005c).", "In contrast, SARS-CoV isolates detected during the brief 2003-2004 re-emergence interacted more weakly with hACE2, but tightly with civet ACE2, and had low pathogenicity and transmissibility (Consortium, 2004; Kan et al., 2005; Li et al., 2005c).", "\u2026phases of the 2002-2003 epidemic were more efficiently transmitted among humans and more pathogenic than the isolates associated with the 2003-2004 re-emergence that caused only a few cases, in line with their binding affinities for hACE2 (Consortium, 2004; Kan et al., 2005; Li et al., 2005c).", "Indeed, specific S mutations enabled efficient binding to hACE2 of SARS-CoV isolates from the three phases of the 2002-2003 epidemic, which were associated with marked disease severity (Consortium, 2004; Kan et al., 2005; Li et al., 2005c; Sui et al., 2004).", "Indeed, specific SB mutations enabled efficient binding to hACE2 of SARS-CoV isolates from the three phases of the 2002-2003 epidemic, which were associated with marked disease severity (Consortium, 2004; Kan et al., 2005; Li et al., 2005c; Sui et al., 2004)."], "isInfluential": true}, "4464714": {"intents": ["result", "background"], "contexts": ["Both SARS-CoV and SARS-CoV-2 are closely related to each other and originated in bats which most likely serve as reservoir host for these two viruses (Ge et al., 2013; Hu et al., 2017; Li et al., 2005b; Yang et al., 2015a; Zhou et al., 2020).", "The latter two SARSr-CoV sequences were identified from Rinolophus sinicus (Chinese horseshoe bats), the species from which SARSr-CoV WIV-1 and WIV-16 were isolated (Ge et al., 2013; Yang et al., 2015a).", "These observations are in line with (i) the fact that some, but not all of these viruses use ACE2 as entry receptor (Ge et al., 2013; Ren et al., 2008; Yang et al., 2015a); and (ii) that the S1 subunit is more exposed at the viral surface than the fusion machinery, and is likely to be subject to a\u2026", "\u2026in bats, including many SARS-related coronaviruses (SARSr-CoVs), suggest that future zoonotic transmission events may continue to occur (Anthony et al., 2017; Ge et al., 2013; Hu et al., 2017; Li et al., 2005b; Menachery et al., 2015; Menachery et al., 2016; Yang et al., 2015a; Zhou et al., 2020).", "SARS-CoV and several SARS-related coronaviruses (SARSr-CoV) interact directly with angiotensin-converting enzyme 2 (ACE2) via SB to enter target cells (Ge et al., 2013; Kirchdoerfer et al., 2018; Li et al., 2005a; Li et al., 2003; Song et al., 2018; Yang et al., 2015a)."], "isInfluential": true}, "205285052": {"intents": [], "contexts": [], "isInfluential": false}, "39590027": {"intents": ["background"], "contexts": ["\u2026a prefusion stabilized ectodomain trimer construct with an abrogated furin S1/S2 cleavage site (Tortorici et al., 2019; Walls et al., 2017a; Walls et al., 2016a; Walls et al., 2019), two consecutive proline stabilizing mutations (Kirchdoerfer et al., 2018; Pallesen et al., 2017) and a\u2026", "As HCoV-NL63 and HCoV-229E are known to engage protein receptors through SB (Wong et al., 2017; Wu et al., 2009), trimer opening is also expected to occur to expose their receptor-recognition motifs that are otherwise buried at the interface between protomers in the closed S trimer (Li et al., 2019; Walls et al., 2016b).", "\u2026are known to engage protein receptors through SB (Wong et al., 2017; Wu et al., 2009), trimer opening is also expected to occur to expose their receptor-recognition motifs that are otherwise buried at the interface between protomers in the closed S trimer (Li et al., 2019; Walls et al., 2016b).", "\u2026CoVs, S is cleaved at the boundary between the S1 and S2 subunits which remain non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 2003; Burkard et al., 2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2016a).", "\u2026cross-react and neutralize the two viruses as well as related coronaviruses (Fig S3 G-H) We previously showed that coronavirus S glycoproteins are densely decorated by heterogeneous N-linked glycans protruding from the trimer surface (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017).", "\u2026domain(s), and contributes to stabilization of the prefusion state of the membrane-anchored S2 subunit that contains the fusion machinery (Gui et al., 2017; Kirchdoerfer et al., 2016; Pallesen et al., 2017; Song et al., 2018; Walls et al., 2016a; Walls et al., 2017b; Yuan et al., 2017).", "\u2026including SARS-CoV S (Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Park et al., 2019; Song et al., 2018; Tortorici et al., 2019; Walls et al., 2016a; Walls et al., 2016b; Walls et al., 2019; Yuan et al., 2017), the S1 subunit has a V-shaped architecture (Fig S3 B-E).", "S trimers are extensively decorated with N-linked glycans that are important for proper folding (Rossen et al., 1998) and to modulate accessibility to host proteases and neutralizing antibodies (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017; Yang et al., 2015b).", "In addition to the highly pathogenic zoonotic pathogens SARS-CoV, MERS-CoV and SARS-CoV-2, all belonging to the \u03b2-coronavirus genus, four low pathogenicity coronaviruses are endemic in humans: HCoV-OC43, HCoV-HKU1, HCoV-NL63 and HCoV-229E.", "In contrast, only closed S trimers have been detected for HCoV-NL63 (Walls et al., 2016b), HCoV-OC43 (Tortorici et al., 2019), HCoV-HKU1 (Kirchdoerfer et al., 2016) and HCoV-229E (Li et al., 2019).", "We previously suggested coronaviruses use conformational masking and glycan shielding to limit recognition by the immune response of infected hosts (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017)."], "isInfluential": true}, "14673375": {"intents": [], "contexts": [], "isInfluential": false}, "47333735": {"intents": [], "contexts": [], "isInfluential": false}, "6938603": {"intents": [], "contexts": [], "isInfluential": false}, "4423127": {"intents": [], "contexts": [], "isInfluential": false}, "35804207": {"intents": ["background"], "contexts": ["For many CoVs, S is cleaved at the boundary between the S1 and S2 subunits which remain non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 2003; Burkard et al., 2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2016a).", "\u2026CoVs, S is cleaved at the boundary between the S1 and S2 subunits which remain non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 2003; Burkard et al., 2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2016a)."], "isInfluential": false}, "20783605": {"intents": [], "contexts": [], "isInfluential": false}, "204884291": {"intents": [], "contexts": [], "isInfluential": false}, "210886197": {"intents": ["background"], "contexts": ["\u2026pneumonia in humans since the beginning of the 21st century: severe acute respiratory syndrome coronavirus (SARS-CoV) (Drosten et al., 2003; Ksiazek et al., 2003), Middle-East respiratory syndrome coronavirus (Zaki et al., 2012) (MERS-CoV) and SARS-CoV-2 (Huang et al., 2020; Zhu et al., 2020)."], "isInfluential": false}, "58668373": {"intents": [], "contexts": [], "isInfluential": false}, "2757258": {"intents": ["result"], "contexts": ["These results demonstrate hACE2 is a functional receptor for SARS-CoV-2, in agreement with recently reported findings (Hoffmann et al., 2020; Letko and Munster, 2020; Zhou et al., 2020)."], "isInfluential": false}, "4083854": {"intents": ["background"], "contexts": [", 2019) and promote subsequent binding of domain B (S) to the entry receptor, dipeptidyl-peptidase 4 (Lu et al., 2013; Raj et al., 2013).", "MERS-CoV S, however, uses domain A to engage non-acetylated sialosides as attachment receptors (Li et al., 2017; Park et al., 2019) and promote subsequent binding of domain B (SB) to the entry receptor, dipeptidyl-peptidase 4 (Lu et al., 2013; Raj et al., 2013)."], "isInfluential": false}, "4422305": {"intents": ["background"], "contexts": [", 2019) and promote subsequent binding of domain B (S) to the entry receptor, dipeptidyl-peptidase 4 (Lu et al., 2013; Raj et al., 2013).", "MERS-CoV S, however, uses domain A to engage non-acetylated sialosides as attachment receptors (Li et al., 2017; Park et al., 2019) and promote subsequent binding of domain B (SB) to the entry receptor, dipeptidyl-peptidase 4 (Lu et al., 2013; Raj et al., 2013)."], "isInfluential": false}, "32435179": {"intents": ["background"], "contexts": ["We note that most SARS-CoV neutralizing Abs isolated to date target the S domain and several of them recognize the RBM and prevent receptor engagement (Hwang et al., 2006; Rockx et al., 2008; Rockx et al., 2010; Traggiai et al., 2004; Walls et al., 2019).", "We previously characterized potent human neutralizing Abs from rare memory B cells of individuals infected with SARS-CoV (Traggiai et al., 2004) or MERS-CoV (Corti et al., 2015) in complex with SARS-CoV S and MERS-CoV S to provide molecular-level information of the mechanism of competitive\u2026", "We previously characterized potent human neutralizing Abs from rare memory B cells of individuals infected with SARS-CoV (Traggiai et al., 2004) or MERS-CoV (Corti et al.", "We note that most SARS-CoV neutralizing Abs isolated to date target the SB domain and several of them recognize the RBM and prevent receptor engagement (Hwang et al., 2006; Rockx et al., 2008; Rockx et al., 2010; Traggiai et al., 2004; Walls et al., 2019)."], "isInfluential": true}, "8976561": {"intents": ["background"], "contexts": ["\u2026an abrogated furin S1/S2 cleavage site (Tortorici et al., 2019; Walls et al., 2017a; Walls et al., 2016a; Walls et al., 2019), two consecutive proline stabilizing mutations (Kirchdoerfer et al., 2018; Pallesen et al., 2017) and a C-terminal foldon trimerization domain (Miroshnikov et al., 1998)."], "isInfluential": false}, "205420862": {"intents": [], "contexts": [], "isInfluential": false}, "22613160": {"intents": ["background"], "contexts": ["We previously showed that coronavirus S glycoproteins are densely decorated by heterogeneous N-linked glycans protruding from the trimer surface (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017).", "We previously suggested coronaviruses use conformational masking and glycan shielding to limit recognition by the immune response of infected hosts (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017).", "S trimers are extensively decorated with N-linked glycans that are important for proper folding (Rossen et al., 1998) and to modulate accessibility to host proteases and neutralizing antibodies (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017; Yang et al., 2015b).", "\u2026cross-react and neutralize the two viruses as well as related coronaviruses (Fig S3 G-H) We previously showed that coronavirus S glycoproteins are densely decorated by heterogeneous N-linked glycans protruding from the trimer surface (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017)."], "isInfluential": false}, "8788287": {"intents": ["background"], "contexts": ["For instance, entry of the MERS-CoV-related bat coronavirus HKU4 into human cells required addition of exogenous trypsin, indicating that S proteolytic activation of this bat virus did not occur in human cells (despite its ability to recognize human DPP4)(Wang et al., 2014; Yang et al., 2014).", "The observed conformational variability of SB domains is reminiscent of observations made with SARS-CoV S and MERS-CoV S trimers although we did not detect trimers with two SB domains open and the distribution of particles across the S conformational landscape varies among studies (Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Song et al., 2018; Walls et al., 2019; Yuan et al., 2017).", "We previously characterized potent human neutralizing Abs from rare memory B cells of individuals infected with SARS-CoV (Traggiai et al., 2004) or MERS-CoV (Corti et al., 2015) in complex with SARS-CoV S and MERS-CoV S to provide molecular-level information of the mechanism of competitive inhibition of SB attachment to the host receptor (Walls et al., 2019).", "MERS-CoV S, however, uses domain A to engage non-acetylated sialosides as attachment receptors (Li et al., 2017; Park et al., 2019) and promote subsequent binding of domain B (SB) to the entry receptor, dipeptidyl-peptidase 4 (Lu et al., 2013; Raj et al., 2013).", "\u2026characterized potent human neutralizing Abs from rare memory B cells of individuals infected with SARS-CoV (Traggiai et al., 2004) or MERS-CoV (Corti et al., 2015) in complex with SARS-CoV S and MERS-CoV S to provide molecular-level information of the mechanism of competitive inhibition of SB\u2026", "We determined a cryo-electron microscopy structure of the SARS-CoV-2 S ectodomain trimer and reveal that it adopts multiple SB conformations that are reminiscent of previous reports on both SARS-CoV S and MERS-CoV S. Finally, we show that SARS-CoV S mouse polyclonal sera potently inhibited entry into target cells of SARS-CoV-2 S pseudotyped viruses.", "Based on the aforementioned data correlating the binding affinity of SARS-CoV for hACE2 with the rate of transmissibility, viral replication in distinct species and disease severity (Guan et al., 2003; Li et al., 2004; Li et al., 2005c; Wan et al., 2020), we hypothesize that the most pathogenic coronaviruses will exhibit S glycoprotein trimers spontaneously sampling closed and open conformations, as is the case for SARS-CoV-2, SARS-CoV and MERS-CoV.", "Three coronaviruses have crossed the species barrier to cause deadly pneumonia in humans since the beginning of the 21st century: severe acute respiratory syndrome coronavirus (SARS-CoV) (Drosten et al., 2003; Ksiazek et al., 2003), Middle-East respiratory syndrome coronavirus (Zaki et al., 2012) (MERS-CoV) and SARS-CoV-2 (Huang et al., 2020; Zhu et al., 2020).", "MERS-CoV was suggested to originate from bats but the reservoir host fueling spillover to humans is unequivocally dromedary camels (Haagmans et al., 2014; Memish et al., 2013).", "Similarly to SARS-CoV S and MERS-CoV S (Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Song et al., 2018; Walls et al., 2019; Yuan et al., 2017), we found that the SARS-CoV-2 S trimer exist in multiple, distinct conformational states resulting from SB opening at the trimer apex.", "In 2012, MERS-CoV emerged in the Arabian Peninsula, where it remains a major public health concern, and was exported to 27 countries, infecting a total of ~2,494 individuals and claiming 858 lives.", "In addition to the highly pathogenic zoonotic pathogens SARS-CoV, MERS-CoV and SARS-CoV-2, all belonging to the \u03b2-coronavirus genus, four low pathogenicity coronaviruses are endemic in humans: HCoV-OC43, HCoV-HKU1, HCoV-NL63 and HCoV-229E."], "isInfluential": true}, "22112982": {"intents": ["background", "methodology"], "contexts": ["Three coronaviruses have crossed the species barrier to cause deadly pneumonia in humans since the beginning of the 21 century: severe acute respiratory syndrome coronavirus (SARS-CoV) (Drosten et al., 2003; Ksiazek et al., 2003), MiddleEast respiratory syndrome coronavirus (Zaki et al.", "\u2026barrier to cause deadly pneumonia in humans since the beginning of the 21st century: severe acute respiratory syndrome coronavirus (SARS-CoV) (Drosten et al., 2003; Ksiazek et al., 2003), Middle-East respiratory syndrome coronavirus (Zaki et al., 2012) (MERS-CoV) and SARS-CoV-2 (Huang et\u2026", "To assess the ability of SARS-CoV-2 S to promote entry into target cells, we first compared transduction of SARS-CoV-2 S-MLV and SARS-CoV S-MLV into VeroE6 cells, that are known to express ACE2 and support SARS-CoV replication (Drosten et al., 2003; Ksiazek et al., 2003)."], "isInfluential": false}, "3023892": {"intents": ["background"], "contexts": ["in the fusion glycoprotein of SARS-CoV-2 could putatively expand its tropism and/or enhance its transmissibility, compared to SARS-CoV and SARSr-CoV isolates, due to the near-ubiquitous distribution of furin-like proteases and their reported effects on other viruses (Klenk and Garten, 1994; Millet and Whittaker, 2015; Steinhauer, 1999) .", "The presence of a polybasic cleavage site, that can be processed by furin-like proteases, is a signature of several highly pathogenic avian influenza viruses and pathogenic Newcastle disease virus (Klenk and Garten, 1994; Steinhauer, 1999).", "\u2026this cleavage motif moderately affected SARS-CoV-2 S-mediated entry into VeroE6 or BHK cells but may contribute to expand the tropism of this virus, as reported for several highly pathogenic avian influenza viruses and pathogenic Newcastle disease virus (Klenk and Garten, 1994; Steinhauer, 1999).", "Abrogation of this cleavage motif moderately affected SARS-CoV-2 Smediated entry into VeroE6 or BHK cells but may contribute to expand the tropism of this virus, as reported for several highly pathogenic avian influenza viruses and pathogenic Newcastle disease virus (Klenk and Garten, 1994; Steinhauer, 1999).", "\u2026could putatively expand its tropism and/or enhance its transmissibility, compared to SARS-CoV and SARSr-CoV isolates, due to the near-ubiquitous distribution of furin-like proteases and their reported effects on other viruses (Klenk and Garten, 1994; Millet and Whittaker, 2015; Steinhauer, 1999)."], "isInfluential": true}, "59527793": {"intents": [], "contexts": [], "isInfluential": false}, "9598200": {"intents": ["background", "methodology"], "contexts": ["\u2026deadly pneumonia in humans since the beginning of the 21st century: severe acute respiratory syndrome coronavirus (SARS-CoV) (Drosten et al., 2003; Ksiazek et al., 2003), Middle-East respiratory syndrome coronavirus (Zaki et al., 2012) (MERS-CoV) and SARS-CoV-2 (Huang et al., 2020; Zhu et al.,\u2026", "To assess the ability of SARS-CoV-2 S to promote entry into target cells, we first compared transduction of SARS-CoV-2 S-MLV and SARS-CoV S-MLV into VeroE6 cells, that are known to express ACE2 and support SARS-CoV replication (Drosten et al., 2003; Ksiazek et al., 2003)."], "isInfluential": false}, "213868150": {"intents": ["result"], "contexts": ["a functional receptor for SARS-CoV-2, in agreement with recently reported findings (Hoffmann et al., 2020; Letko and Munster, 2020; Zhou et al., 2020).", "These results demonstrate hACE2 is a functional receptor for SARS-CoV-2, in agreement with recently reported findings (Hoffmann et al., 2020; Letko and Munster, 2020; Zhou et al., 2020)."], "isInfluential": false}, "7919831": {"intents": ["methodology"], "contexts": ["The model was subsequently manually rebuilt using Coot and the C3-symmetrized map (Brown et al., 2015; Emsley et al., 2010)."], "isInfluential": false}, "15830721": {"intents": [], "contexts": ["Analysis of the 104 SARS-CoV-2 genome sequences available from GISAID (Elbe and Buckland-Merrett, 2017) shows that 8 out of these 14 positions are strictly conserved in SARS-CoV-2 SB whereas the other 6 positions are (semi)-conservatively substituted: R426SARS-CoVN448SARS-CoV-2, Y442SARS-CoVL464SARS-CoV-2, L472SARS-CoVF495SARS-CoV-2, N479SARS-CoVQ502SARS-CoV-2, Y484SARS-CoVQ507SARS-CoV-2, T487SARS-CoVN510SARS-CoV-2 (Fig.", "Analysis of the 104 SARS-CoV-2 genome sequences available from GISAID (Elbe and Buckland-Merrett, 2017) shows that 8 out of these 14 positions are strictly conserved in SARS-CoV-2 SB whereas the other 6 positions are (semi)-conservatively substituted: R426SARS-CoVN448SARS-CoV-2,\u2026"], "isInfluential": false}, "5953778": {"intents": ["background"], "contexts": ["\u2026in bats, including many SARS-related coronaviruses (SARSr-CoVs), suggest that future zoonotic transmission events may continue to occur (Anthony et al., 2017; Ge et al., 2013; Hu et al., 2017; Li et al., 2005b; Menachery et al., 2015; Menachery et al., 2016; Yang et al., 2015a; Zhou et al., 2020).", "The recurrent spillovers of coronaviruses in humans along with detection of numerous coronaviruses in bats, including many SARS-related coronaviruses (SARSr-CoVs), suggest that future zoonotic transmission events may continue to occur (Anthony et al., 2017; Ge et al., 2013; Hu et al., 2017; Li et al., 2005b; Menachery et al., 2015; Menachery et al., 2016; Yang et al., 2015a; Zhou et al., 2020)."], "isInfluential": false}, "18616253": {"intents": ["background"], "contexts": ["We note that most SARS-CoV neutralizing Abs isolated to date target the S domain and several of them recognize the RBM and prevent receptor engagement (Hwang et al., 2006; Rockx et al., 2008; Rockx et al., 2010; Traggiai et al., 2004; Walls et al., 2019).", "We note that most SARS-CoV neutralizing Abs isolated to date target the SB domain and several of them recognize the RBM and prevent receptor engagement (Hwang et al., 2006; Rockx et al., 2008; Rockx et al., 2010; Traggiai et al., 2004; Walls et al., 2019)."], "isInfluential": false}, "1028282": {"intents": [], "contexts": [], "isInfluential": false}, "210256130": {"intents": [], "contexts": [], "isInfluential": false}, "11345705": {"intents": ["background"], "contexts": ["\u2026CoVs, S is cleaved at the boundary between the S1 and S2 subunits which remain non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 2003; Burkard et al., 2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2016a)."], "isInfluential": false}, "45532137": {"intents": ["background"], "contexts": ["We note that most SARS-CoV neutralizing Abs isolated to date target the SB domain and several of them recognize the RBM and prevent receptor engagement (Hwang et al., 2006; Rockx et al., 2008; Rockx et al., 2010; Traggiai et al., 2004; Walls et al., 2019)."], "isInfluential": false}, "206804617": {"intents": ["background"], "contexts": ["\u2026cleavage site sets SARS-CoV-2 S apart from SARS-CoV S (and SARSr-CoV S) that possesses a monobasic S1/S2 cleavage site processed upon entry of target cells (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "\u2026studies also showed that the host proteases cathepsin L and TMPRSS2 prime SARS-CoV S for membrane fusion through cleavage at the S1/S2 and at the S2\u2019 sites (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011)."], "isInfluential": false}, "42027492": {"intents": [], "contexts": [], "isInfluential": false}, "38967420": {"intents": ["background"], "contexts": ["\u2026cleavage site sets SARS-CoV-2 S apart from SARS-CoV S (and SARSr-CoV S) that possesses a monobasic S1/S2 cleavage site processed upon entry of target cells (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "The presence of a furin cleavage site sets SARS-CoV-2 S apart from SARS-CoV S (and SARSr-CoV S) that possesses a monobasic S1/S2 cleavage site processed upon entry of target cells (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "Previous studies also showed that the host proteases cathepsin L and TMPRSS2 prime SARS-CoV S for membrane fusion through cleavage at the S1/S2 and at the S2\u2019 sites (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "\u2026studies also showed that the host proteases cathepsin L and TMPRSS2 prime SARS-CoV S for membrane fusion through cleavage at the S1/S2 and at the S2\u2019 sites (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011)."], "isInfluential": true}, "53044258": {"intents": [], "contexts": [], "isInfluential": false}, "23839867": {"intents": [], "contexts": [], "isInfluential": false}, "12205421": {"intents": [], "contexts": [], "isInfluential": false}, "213842070": {"intents": ["result"], "contexts": ["a functional receptor for SARS-CoV-2, in agreement with recently reported findings (Hoffmann et al., 2020; Letko and Munster, 2020; Zhou et al., 2020).", "These results demonstrate hACE2 is a functional receptor for SARS-CoV-2, in agreement with recently reported findings (Hoffmann et al., 2020; Letko and Munster, 2020; Zhou et al., 2020)."], "isInfluential": false}, "13374021": {"intents": [], "contexts": ["Figures were generated using UCSF ChimeraX (Goddard et al., 2018)."], "isInfluential": false}, "38336021": {"intents": ["background"], "contexts": ["This cleavage has been proposed to activate the protein for membrane fusion via extensive irreversible conformational changes (Belouzard et al., 2009; Heald-Sargent and Gallagher, 2012; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2017b)."], "isInfluential": false}, "211022984": {"intents": ["result", "background"], "contexts": ["These results demonstrate hACE2 is a functional receptor for SARS-CoV-2, in agreement with recently reported findings (Hoffmann et al., 2020; Letko and Munster, 2020; Zhou et al., 2020).", "A previously unknown coronavirus, named SARS-CoV-2, was discovered in December 2019 in Wuhan, Hubei Province of China and was sequenced and isolated by January 2020 (Zhou et al., 2020; Zhu et al., 2020).", "Both SARS-CoV and SARS-CoV-2 are closely related to each other and originated in bats which most likely serve as reservoir host for these two viruses (Ge et al., 2013; Hu et al., 2017; Li et al., 2005b; Yang et al., 2015a; Zhou et al., 2020).", "This results in the introduction of a furin cleavage site, a feature conserved among the 103 SARS-CoV-2 isolates sequenced to date but not in the closely related RaTG13 S (Zhou et al., 2020).", "Furthermore, Zhou et al recently reported that SARS-CoV-2 is most closely related to the bat SARSr-CoV RaTG13 with which it forms a distinct lineage from other SARSr-CoVs, and that their S glycoproteins share 98% amino acid sequence identity (Zhou et al., 2020).", "a functional receptor for SARS-CoV-2, in agreement with recently reported findings (Hoffmann et al., 2020; Letko and Munster, 2020; Zhou et al., 2020).", "site, a feature conserved among the 103 SARS-CoV-2 isolates sequenced to date but not in the closely related RaTG13 S (Zhou et al., 2020).", "The recurrent spillovers of coronaviruses in humans along with detection of numerous coronaviruses in bats, including many SARS-related coronaviruses (SARSr-CoVs), suggest that future zoonotic transmission events may continue to occur (Anthony et al., 2017; Ge et al., 2013; Hu et al., 2017; Li et al., 2005b; Menachery et al., 2015; Menachery et al., 2016; Yang et al., 2015a; Zhou et al., 2020).", "\u2026in bats, including many SARS-related coronaviruses (SARSr-CoVs), suggest that future zoonotic transmission events may continue to occur (Anthony et al., 2017; Ge et al., 2013; Hu et al., 2017; Li et al., 2005b; Menachery et al., 2015; Menachery et al., 2016; Yang et al., 2015a; Zhou et al., 2020)."], "isInfluential": true}, "20347301": {"intents": ["background"], "contexts": ["\u2026cleavage site sets SARS-CoV-2 S apart from SARS-CoV S (and SARSr-CoV S) that possesses a monobasic S1/S2 cleavage site processed upon entry of target cells (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "\u2026studies also showed that the host proteases cathepsin L and TMPRSS2 prime SARS-CoV S for membrane fusion through cleavage at the S1/S2 and at the S2\u2019 sites (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011)."], "isInfluential": false}, "5401802": {"intents": ["background"], "contexts": ["For many CoVs, S is cleaved at the boundary between the S1 and S2 subunits which remain non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 2003; Burkard et al., 2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al.,\u2026", "\u2026cleavage site sets SARS-CoV-2 S apart from SARS-CoV S (and SARSr-CoV S) that possesses a monobasic S1/S2 cleavage site processed upon entry of target cells (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011).", "This cleavage has been proposed to activate the protein for membrane fusion via extensive irreversible conformational changes (Belouzard et al., 2009; Heald-Sargent and Gallagher, 2012; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2017b).", "\u2026studies also showed that the host proteases cathepsin L and TMPRSS2 prime SARS-CoV S for membrane fusion through cleavage at the S1/S2 and at the S2\u2019 sites (Belouzard et al., 2009; Bosch et al., 2008; Glowacka et al., 2011; Matsuyama et al., 2010; Millet and Whittaker, 2015; Shulla et al., 2011)."], "isInfluential": true}, "7199366": {"intents": ["background"], "contexts": ["Endemic human coronaviruses OC43 and HKU1 attach via their S domain A (SA) to 5-N-acetyl-9-O-acetyl-sialosides found on glycoproteins and glycolipids at the host cell surface to enable entry into susceptible cells (Hulswit et al., 2019; Tortorici et al., 2019; Vlasak et al., 1988).", "Endemic human coronaviruses OC43 and HKU1 attach via their S domain A (S) to 5-N-acetyl-9O-acetyl-sialosides found on glycoproteins and glycolipids at the host cell surface to enable entry into susceptible cells (Hulswit et al., 2019; Tortorici et al., 2019; Vlasak et al., 1988)."], "isInfluential": false}, "35191346": {"intents": [], "contexts": [], "isInfluential": false}, "13163032": {"intents": ["background"], "contexts": ["Moreover, the ability to engage ACE2 from different animal species appears to reflect host susceptibility to SARS-CoV infection and facilitated the jump of the virus from animals to humans (Li, 2008; Li et al., 2004)."], "isInfluential": false}, "32909984": {"intents": ["background"], "contexts": ["As HCoV-NL63 and HCoV229E are known to engage protein receptors through S (Wong et al., 2017; Wu et al., 2009), trimer opening is also expected to occur to expose their receptor-recognition motifs that are otherwise buried at the interface between protomers in the closed S trimer (Li et al.", "As HCoV-NL63 and HCoV-229E are known to engage protein receptors through SB (Wong et al., 2017; Wu et al., 2009), trimer opening is also expected to occur to expose their receptor-recognition motifs that are otherwise buried at the interface between protomers in the closed S trimer (Li et al.,\u2026"], "isInfluential": false}, "33800088": {"intents": [], "contexts": [], "isInfluential": false}, "12438123": {"intents": [], "contexts": [], "isInfluential": false}, "11179607": {"intents": ["background"], "contexts": ["For instance, entry of the MERS-CoV-related bat coronavirus HKU4 into human cells required addition of exogenous trypsin, indicating that S proteolytic activation of this bat virus did not occur in human cells (despite its ability to recognize human DPP4)(Wang et al., 2014; Yang et al., 2014)."], "isInfluential": false}, "4469114": {"intents": ["background"], "contexts": ["The distal S1 subunit comprises the receptor-binding domain(s), and contributes to stabilization of the prefusion state of the membrane-anchored S2 subunit that contains the fusion machinery (Gui et al., 2017; Kirchdoerfer et al., 2016; Pallesen et al., 2017; Song et al., 2018; Walls et al., 2016a; Walls et al., 2017b; Yuan et al., 2017).", "\u2026CoVs, S is cleaved at the boundary between the S1 and S2 subunits which remain non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 2003; Burkard et al., 2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2016a).", ", 2019), HCoV-HKU1 (Kirchdoerfer et al., 2016) and HCoV-229E (Li et al.", "\u2026domain(s), and contributes to stabilization of the prefusion state of the membrane-anchored S2 subunit that contains the fusion machinery (Gui et al., 2017; Kirchdoerfer et al., 2016; Pallesen et al., 2017; Song et al., 2018; Walls et al., 2016a; Walls et al., 2017b; Yuan et al., 2017).", "For many CoVs, S is cleaved at the boundary between the S1 and S2 subunits which remain non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 2003; Burkard et al., 2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2016a).", "In addition to the highly pathogenic zoonotic pathogens SARS-CoV, MERS-CoV and SARS-CoV-2, all belonging to the \u03b2-coronavirus genus, four low pathogenicity coronaviruses are endemic in humans: HCoV-OC43, HCoV-HKU1, HCoV-NL63 and HCoV-229E.", "In contrast, only closed S trimers have been detected for HCoV-NL63 (Walls et al., 2016b), HCoV-OC43 (Tortorici et al., 2019), HCoV-HKU1 (Kirchdoerfer et al., 2016) and HCoV-229E (Li et al., 2019)."], "isInfluential": true}, "24689903": {"intents": ["background"], "contexts": ["Indeed, specific SB mutations enabled efficient binding to hACE2 of SARS-CoV isolates from the three phases of the 2002-2003 epidemic, which were associated with marked disease severity (Consortium, 2004; Kan et al., 2005; Li et al., 2005c; Sui et al., 2004)."], "isInfluential": false}, "23922257": {"intents": [], "contexts": [], "isInfluential": false}, "209070072": {"intents": [], "contexts": [], "isInfluential": false}, "12842082": {"intents": [], "contexts": [], "isInfluential": false}, "1709821": {"intents": [], "contexts": [], "isInfluential": false}, "3976163": {"intents": ["background"], "contexts": ["\u2026CoVs, S is cleaved at the boundary between the S1 and S2 subunits which remain non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 2003; Burkard et al., 2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2016a).", "This cleavage has been proposed to activate the protein for membrane fusion via extensive irreversible conformational changes (Belouzard et al., 2009; Heald-Sargent and Gallagher, 2012; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2017b).", "\u2026cell surface and initiating the conformational changes leading to cleavage of the S2\u2019 site, membrane fusion and viral entry (Gui et al., 2017; Kirchdoerfer et al., 2018; Millet and Whittaker, 2014; Pallesen et al., 2017; Park et al., 2016; Song et al., 2018; Walls et al., 2019; Yuan et al., 2017)."], "isInfluential": false}, "21462590": {"intents": ["result", "background"], "contexts": ["These oligosaccharides participate in S folding (Rossen et al., 1998), they affect priming by host proteases (Yang et al., 2015b) and modulate antibody recognition (Pallesen et al., 2017; Walls et al., 2019).", "Subsequent work suggested that a glycan present near the S1/S2 boundary accounted for the lack of proteolytic priming of HKU4 S and that its removal enhanced pseudovirus entry in human cells (Yang et al., 2015b).", "Both SARS-CoV and SARS-CoV-2 are closely related to each other and originated in bats which most likely serve as reservoir host for these two viruses (Ge et al., 2013; Hu et al., 2017; Li et al., 2005b; Yang et al., 2015a; Zhou et al., 2020).", "\u2026observations are in line with (i) the fact that some, but not all of these viruses use ACE2 as entry receptor (Ge et al., 2013; Ren et al., 2008; Yang et al., 2015a); and (ii) that the S1 subunit is more exposed at the viral surface than the fusion machinery, and is likely to be subject to a\u2026", "The latter two SARSr-CoV sequences were identified from Rinolophus sinicus (Chinese horseshoe bats), the species from which SARSr-CoV WIV-1 and WIV-16 were isolated (Ge et al., 2013; Yang et al., 2015a).", "S trimers are extensively decorated with N-linked glycans that are important for proper folding (Rossen et al., 1998) and to modulate accessibility to host proteases and neutralizing antibodies (Walls et al., 2016b; Walls et al., 2019; Xiong et al., 2017; Yang et al., 2015b).", "\u2026in bats, including many SARS-related coronaviruses (SARSr-CoVs), suggest that future zoonotic transmission events may continue to occur (Anthony et al., 2017; Ge et al., 2013; Hu et al., 2017; Li et al., 2005b; Menachery et al., 2015; Menachery et al., 2016; Yang et al., 2015a; Zhou et al., 2020).", "SARS-CoV and several SARS-related coronaviruses (SARSr-CoV) interact directly with angiotensin-converting enzyme 2 (ACE2) via SB to enter target cells (Ge et al., 2013; Kirchdoerfer et al., 2018; Li et al., 2005a; Li et al., 2003; Song et al., 2018; Yang et al., 2015a)."], "isInfluential": true}, "203853260": {"intents": [], "contexts": [], "isInfluential": false}, "80867103": {"intents": [], "contexts": [], "isInfluential": false}, "59249424": {"intents": ["background"], "contexts": ["We note that most SARS-CoV neutralizing Abs isolated to date target the S domain and several of them recognize the RBM and prevent receptor engagement (Hwang et al., 2006; Rockx et al., 2008; Rockx et al., 2010; Traggiai et al., 2004; Walls et al., 2019).", "We note that most SARS-CoV neutralizing Abs isolated to date target the SB domain and several of them recognize the RBM and prevent receptor engagement (Hwang et al., 2006; Rockx et al., 2008; Rockx et al., 2010; Traggiai et al., 2004; Walls et al., 2019)."], "isInfluential": false}, "210949404": {"intents": ["background", "methodology"], "contexts": ["SARS-CoV-2 recognizes human ACE2 with comparable affinity than SARS-CoV The binding affinity of SARS-CoV for hACE2 correlate with the overall rate of viral replication in distinct species, transmissibility and disease severity (Guan et al., 2003; Li et al., 2004; Li et al., 2005c; Wan et al., 2020).", "\u2026its entry receptor human ACE2 (hACE2) at the surface of type II pneumocytes, using SB which shares ~75% overall amino acid sequence identity with SARS-CoV-2 SB and 50% identity within their receptor-binding motifs (RBMs) (Li et al., 2005a; Li et al., 2003; Li et al., 2005c; Wan et al., 2020).", "\u2026with the rate of transmissibility, viral replication in distinct species and disease severity (Guan et al., 2003; Li et al., 2004; Li et al., 2005c; Wan et al., 2020), we hypothesize that the most pathogenic coronaviruses will exhibit S glycoprotein trimers spontaneously sampling closed and open\u2026"], "isInfluential": false}, "6472160": {"intents": ["background"], "contexts": ["We surmise most of these Abs target the highly conserved S2 subunit (including the fusion peptide region) based on its structural similarity across SARS-CoV-2 and SARS-CoV and previous reports showing that sera from SARS-CoV-infected individuals target this region (Zhang et al., 2004)."], "isInfluential": false}, "51971240": {"intents": ["background"], "contexts": ["\u2026for other \u03b2-coronavirus S glycoproteins, including SARS-CoV S (Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Park et al., 2019; Song et al., 2018; Tortorici et al., 2019; Walls et al., 2016a; Walls et al., 2016b; Walls et al., 2019; Yuan et al., 2017), the S1 subunit has a\u2026", "\u2026collection and refinement statistics Overall, the SARS-CoV-2 S ectodomain is a 160\u00c5-long trimer with a triangular crosssection, resembling the closely related SARS-CoV S structure (Fig S3 A-F)(Gui et al., 2017; Kirchdoerfer et al., 2018; Song et al., 2018; Walls et al., 2019; Yuan et al., 2017).", "\u2026cell surface and initiating the conformational changes leading to cleavage of the S2\u2019 site, membrane fusion and viral entry (Gui et al., 2017; Kirchdoerfer et al., 2018; Millet and Whittaker, 2014; Pallesen et al., 2017; Park et al., 2016; Song et al., 2018; Walls et al., 2019; Yuan et al., 2017).", "\u2026domain(s), and contributes to stabilization of the prefusion state of the membrane-anchored S2 subunit that contains the fusion machinery (Gui et al., 2017; Kirchdoerfer et al., 2016; Pallesen et al., 2017; Song et al., 2018; Walls et al., 2016a; Walls et al., 2017b; Yuan et al., 2017).", "Similarly to SARS-CoV S and MERS-CoV S (Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Song et al., 2018; Walls et al., 2019; Yuan et al., 2017), we found that the SARS-CoV-2 S trimer exist in multiple, distinct conformational states resulting from SB opening at the trimer apex.", "\u2026MERS-CoV S trimers although we did not detect trimers with two SB domains open and the distribution of particles across the S conformational landscape varies among studies (Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Song et al., 2018; Walls et al., 2019; Yuan et al., 2017).", "SARS-CoV and several SARS-related coronaviruses (SARSr-CoV) interact directly with angiotensin-converting enzyme 2 (ACE2) via SB to enter target cells (Ge et al., 2013; Kirchdoerfer et al., 2018; Li et al., 2005a; Li et al., 2003; Song et al., 2018; Yang et al., 2015a).", "These structural changes are necessary for receptor engagement of these three viruses and lead to initiation of fusogenic conformational changes (Song et al., 2018; Walls et al., 2017b; Walls et al., 2019)."], "isInfluential": true}, "53022573": {"intents": ["background"], "contexts": ["The presence of a polybasic cleavage site, that can be processed by furin-like proteases, is a signature of several highly pathogenic avian influenza viruses and pathogenic Newcastle disease virus (Klenk and Garten, 1994; Steinhauer, 1999).", "\u2026this cleavage motif moderately affected SARS-CoV-2 S-mediated entry into VeroE6 or BHK cells but may contribute to expand the tropism of this virus, as reported for several highly pathogenic avian influenza viruses and pathogenic Newcastle disease virus (Klenk and Garten, 1994; Steinhauer, 1999).", "\u2026could putatively expand its tropism and/or enhance its transmissibility, compared to SARS-CoV and SARSr-CoV isolates, due to the near-ubiquitous distribution of furin-like proteases and their reported effects on other viruses (Klenk and Garten, 1994; Millet and Whittaker, 2015; Steinhauer, 1999)."], "isInfluential": false}, "22295718": {"intents": ["background"], "contexts": ["We note that most SARS-CoV neutralizing Abs isolated to date target the SB domain and several of them recognize the RBM and prevent receptor engagement (Hwang et al., 2006; Rockx et al., 2008; Rockx et al., 2010; Traggiai et al., 2004; Walls et al., 2019)."], "isInfluential": false}, "173992314": {"intents": ["background"], "contexts": ["\u2026study of the SARS-CoV-2 S glycoprotein, we designed a prefusion stabilized ectodomain trimer construct with an abrogated furin S1/S2 cleavage site (Tortorici et al., 2019; Walls et al., 2017a; Walls et al., 2016a; Walls et al., 2019), two consecutive proline stabilizing mutations (Kirchdoerfer et\u2026", "\u2026S glycoproteins, including SARS-CoV S (Gui et al., 2017; Kirchdoerfer et al., 2018; Pallesen et al., 2017; Park et al., 2019; Song et al., 2018; Tortorici et al., 2019; Walls et al., 2016a; Walls et al., 2016b; Walls et al., 2019; Yuan et al., 2017), the S1 subunit has a V-shaped architecture\u2026", "Endemic human coronaviruses OC43 and HKU1 attach via their S domain A (SA) to 5-N-acetyl-9-O-acetyl-sialosides found on glycoproteins and glycolipids at the host cell surface to enable entry into susceptible cells (Hulswit et al., 2019; Tortorici et al., 2019; Vlasak et al., 1988).", "In addition to the highly pathogenic zoonotic pathogens SARS-CoV, MERS-CoV and SARS-CoV-2, all belonging to the \u03b2-coronavirus genus, four low pathogenicity coronaviruses are endemic in humans: HCoV-OC43, HCoV-HKU1, HCoV-NL63 and HCoV-229E.", "In contrast, only closed S trimers have been detected for HCoV-NL63 (Walls et al., 2016b), HCoV-OC43 (Tortorici et al., 2019), HCoV-HKU1 (Kirchdoerfer et al., 2016) and HCoV-229E (Li et al., 2019)."], "isInfluential": false}, "7671909": {"intents": ["background"], "contexts": ["\u2026pneumonia in humans since the beginning of the 21st century: severe acute respiratory syndrome coronavirus (SARS-CoV) (Drosten et al., 2003; Ksiazek et al., 2003), Middle-East respiratory syndrome coronavirus (Zaki et al., 2012) (MERS-CoV) and SARS-CoV-2 (Huang et al., 2020; Zhu et al., 2020)."], "isInfluential": false}, "16814314": {"intents": [], "contexts": [], "isInfluential": false}, "202017284": {"intents": [], "contexts": [], "isInfluential": false}, "20912646": {"intents": ["background"], "contexts": ["MERS-CoV S, however, uses domain A to engage non-acetylated sialosides as attachment receptors (Li et al., 2017; Park et al., 2019) and promote subsequent binding of domain B (S) to the entry receptor, dipeptidyl-peptidase 4 (Lu et al.", "MERS-CoV S, however, uses domain A to engage non-acetylated sialosides as attachment receptors (Li et al., 2017; Park et al., 2019) and promote subsequent binding of domain B (SB) to the entry receptor, dipeptidyl-peptidase 4 (Lu et al., 2013; Raj et al., 2013)."], "isInfluential": false}, "36779685": {"intents": ["background"], "contexts": ["\u2026CoVs, S is cleaved at the boundary between the S1 and S2 subunits which remain non-covalently bound in the prefusion conformation (Belouzard et al., 2009; Bosch et al., 2003; Burkard et al., 2014; Kirchdoerfer et al., 2016; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2016a).", "This cleavage has been proposed to activate the protein for membrane fusion via extensive irreversible conformational changes (Belouzard et al., 2009; Heald-Sargent and Gallagher, 2012; Millet and Whittaker, 2014, 2015; Park et al., 2016; Walls et al., 2017b).", "\u2026cell surface and initiating the conformational changes leading to cleavage of the S2\u2019 site, membrane fusion and viral entry (Gui et al., 2017; Kirchdoerfer et al., 2018; Millet and Whittaker, 2014; Pallesen et al., 2017; Park et al., 2016; Song et al., 2018; Walls et al., 2019; Yuan et al., 2017)."], "isInfluential": false}, "2971923": {"intents": [], "contexts": [], "isInfluential": false}, "54460140": {"intents": ["background"], "contexts": ["in the fusion glycoprotein of SARS-CoV-2 could putatively expand its tropism and/or enhance its transmissibility, compared to SARS-CoV and SARSr-CoV isolates, due to the near-ubiquitous distribution of furin-like proteases and their reported effects on other viruses (Klenk and Garten, 1994; Millet and Whittaker, 2015; Steinhauer, 1999) .", "The presence of a polybasic cleavage site, that can be processed by furin-like proteases, is a signature of several highly pathogenic avian influenza viruses and pathogenic Newcastle disease virus (Klenk and Garten, 1994; Steinhauer, 1999).", "\u2026this cleavage motif moderately affected SARS-CoV-2 S-mediated entry into VeroE6 or BHK cells but may contribute to expand the tropism of this virus, as reported for several highly pathogenic avian influenza viruses and pathogenic Newcastle disease virus (Klenk and Garten, 1994; Steinhauer, 1999).", "Abrogation of this cleavage motif moderately affected SARS-CoV-2 Smediated entry into VeroE6 or BHK cells but may contribute to expand the tropism of this virus, as reported for several highly pathogenic avian influenza viruses and pathogenic Newcastle disease virus (Klenk and Garten, 1994; Steinhauer, 1999).", "\u2026could putatively expand its tropism and/or enhance its transmissibility, compared to SARS-CoV and SARSr-CoV isolates, due to the near-ubiquitous distribution of furin-like proteases and their reported effects on other viruses (Klenk and Garten, 1994; Millet and Whittaker, 2015; Steinhauer, 1999)."], "isInfluential": true}, "1186306": {"intents": [], "contexts": [], "isInfluential": false}, "210889724": {"intents": ["background"], "contexts": ["\u2026pneumonia in humans since the beginning of the 21st century: severe acute respiratory syndrome coronavirus (SARS-CoV) (Drosten et al., 2003; Ksiazek et al., 2003), Middle-East respiratory syndrome coronavirus (Zaki et al., 2012) (MERS-CoV) and SARS-CoV-2 (Huang et al., 2020; Zhu et al., 2020).", "A previously unknown coronavirus, named SARS-CoV-2, was discovered in December 2019 in Wuhan, Hubei Province of China and was sequenced and isolated by January 2020 (Zhou et al., 2020; Zhu et al., 2020)."], "isInfluential": false}, "4578178": {"intents": ["background"], "contexts": ["\u2026in bats, including many SARS-related coronaviruses (SARSr-CoVs), suggest that future zoonotic transmission events may continue to occur (Anthony et al., 2017; Ge et al., 2013; Hu et al., 2017; Li et al., 2005b; Menachery et al., 2015; Menachery et al., 2016; Yang et al., 2015a; Zhou et\u2026"], "isInfluential": false}}, "publish_time": "2020-02-20", "journal": "bioRxiv"}, "231299808": {"label": "SUPPORT", "evidence": ["Except for a SNP causing a nonsense mutation that reduced ACE2 expression, none of the selected SNPs markedly altered the interaction between ACE2 and the SARS-CoV-2 spike protein (SARS-2-S), which is responsible for receptor recognition and cell entry, or the efficiency of viral cell entry mediated by SARS-2-S. Our findings indicate that ACE2 polymorphisms have limited impact on the ACE2-dependent cell entry of SARS-CoV-2 and underscore the importance of future studies on the involvement of population-specific SNPs of other host genes in susceptibility toward SARS-CoV-2 infection."], "aliases": [], "pinfo": {"citationCount": 10, "influentialCitationCount": 0}, "ainfo": {"authors": ["1453132547", "145286665", "6508449", "2027213685", "11084092"], "numAuthors": 5, "maxPaperCount": 67, "medianPaperCount": 27, "maxCitationCount": 1259, "medianCitationCount": 579, "maxHIndex": 18, "medianHIndex": 13}, "rinfo": {"224823992": {"isInfluential": false, "contexts": [], "intents": []}, "13131970": {"isInfluential": false, "contexts": ["The signal intensities of the visualized protein bands were determined with ImageJ software [15]."], "intents": ["methodology"]}, "216128436": {"isInfluential": false, "contexts": [], "intents": []}, "4389490": {"isInfluential": false, "contexts": ["ACE2, encoded on the X chromosome, is a type I cell-surface glycoprotein with peptidase activity that contributes toward the control of blood pressure by regulating the renin\u2013angiotensin\u2013aldosterone system [2]."], "intents": ["background"]}, "36265906": {"isInfluential": false, "contexts": ["HEK293T cells transfected for 24 h with a plasmid expressing the C-terminal 19 amino acid-deleted SARS-2-S (codon-optimized for human cells) containing the D614G substitution (pCAGG-SARS2-SHu\u220619-D614G) were inoculated with pseudotyped VSV complemented with the VSV glycoprotein (G), where the G gene was replaced with the green fluorescent protein (GFP) gene [14], at a multiplicity of infection (MOI) of 5."], "intents": ["methodology"]}, "3302352": {"isInfluential": false, "contexts": [], "intents": []}, "221257976": {"isInfluential": false, "contexts": ["In contrast to recent reports [9,10,20,21], the cells expressing the ACE2 variants, except for ACE2(L656X), bound to rSARS-2-S1(D614G) with similar efficiency to those expressing WT ACE2."], "intents": ["result"]}, "218470807": {"isInfluential": true, "contexts": ["These comprised S19P and K26R, reported to potentially affect ACE2 affinity toward SARS2-S [9,10], as well as N720D, which is located far from the SARS-2-S binding domain and is, therefore, expected to have little impact on SARS-2-S binding [10]; these three SNPs are common in American and Non-Finnish European populations.", "included two SNPs, S19P and K26R, which are reported to potentially affect ACE2 affinity toward SARS-2-S [9,10], and another SNP, N720D, which is located far from the SARS-2-S binding domain and is, therefore, expected to have little impact on SARS-2-S binding [10].", "reported that S19P (a SNP common in African populations) and K26R (a SNP common in European populations) may decrease and increase the binding affinity of ACE2 toward SARS-2-S, respectively [9].", "These included two SNPs, S19P and K26R, which are reported to potentially affect ACE2 affinity toward SARS-2-S [9,10], and another SNP, N720D, which is located far from the SARS-2-S binding domain and is, therefore, expected to have little impact on SARS-2-S binding [10].", "In contrast to recent reports [9,10,20,21], the cells expressing the ACE2 variants, except for ACE2(L656X), bound to rSARS-2-S1(D614G) with similar efficiency to those expressing WT ACE2."], "intents": ["result", "background"]}, "224810943": {"isInfluential": false, "contexts": ["Consistent with previous observations [18], the HEK293T cells transfected with an empty plasmid (no ACE2 insert) did not exhibit a detectable level of endogenous ACE2."], "intents": ["result"]}, "43990087": {"isInfluential": false, "contexts": ["The Genome Aggregation Database (gnomAD), the Japanese Multi Omics Reference Panel (jMorp) [11], and the 1000 Genomes Project [12] databases were used to identify population-specific ACE2 SNPs.", "To investigate this possibility, we searched the Genome Aggregation Database (gnomAD), the Japanese Multi Omics Reference Panel (jMorp) [11], and the 1000 Genomes Project [12] databases to identify SNPs in the ACE2 gene, causing amino acid changes at the protein level."], "intents": ["methodology"]}, "211265696": {"isInfluential": false, "contexts": [], "intents": []}, "219604383": {"isInfluential": false, "contexts": ["In addition to ACE2, other host factors, such as TMPRSS2 for S protein priming and the most recently identified cell entry receptor for SARS-CoV-2, neuropilin1, play critical roles in SARS-CoV-2 multiplication [1,26,27]."], "intents": ["background"]}, "214779011": {"isInfluential": false, "contexts": ["Recent reports indicate that ACE2 cleaved by ADAM17 is released into the extracellular space [24] and this soluble form of ACE2 interacts with SARS-2-S on cell-free SARS-CoV-2 virions, leading to the inhibition of viral infection [25]."], "intents": ["background"]}, "219904370": {"isInfluential": false, "contexts": ["Recent in silico studies on TMPRSS2 indicated that several TMPRSS2 SNPs potentially affect SARS-CoV-2 infectivity and contribute toward COVID-19 severity [6,7]."], "intents": ["background"]}, "214809788": {"isInfluential": false, "contexts": ["In contrast to recent reports [9,10,20,21], the cells expressing the ACE2 variants, except for ACE2(L656X), bound to rSARS-2-S1(D614G) with similar efficiency to those expressing WT ACE2."], "intents": ["result"]}, "42027492": {"isInfluential": false, "contexts": ["Although the selected SNPs are not in the amino acid residues critical for SARS-S [16] or SARS-2-S [17] binding (Figure 1), molecular dynamics simulations have indicated that some of these SNPs may potentially affect the affinity of ACE2 toward SARS-2-S.", "The amino acid positions corresponding to the selected SNPs were distantly mapped from the region previously reported to be important for binding to the SARSCoV S protein [16] but are considered to also be important for binding to SARS-2-S based on data from the crystal structure of the ACE2 and SARS-2-S complex [17] (Figure 1).", "The amino acid positions corresponding to the selected SNPs were distantly mapped from the region previously reported to be important for binding to the SARS-CoV S protein [16] but are considered to also be important for binding to SARS-2-S based on data from the crystal structure of the ACE2 and SARS-2-S complex [17] (Figure 1)."], "intents": ["methodology", "background"]}, "220304292": {"isInfluential": false, "contexts": ["For this, HEK293T cells transfected with plasmids expressing WT ACE2 or the ACE2 variants were incubated with recombinant SARS-2-S1 containing the D614G mutation [rSARS-2-S1(D614G)], a mutation that is currently found in the most prevalent strains of SARS-CoV-2 worldwide [19]."], "intents": ["methodology"]}, "214731733": {"isInfluential": false, "contexts": ["Although the selected SNPs are not in the amino acid residues critical for SARS-S [16] or SARS-2-S [17] binding (Figure 1), molecular dynamics simulations have indicated that some of these SNPs may potentially affect the affinity of ACE2 toward SARS-2-S.", "The amino acid positions corresponding to the selected SNPs were distantly mapped from the region previously reported to be important for binding to the SARSCoV S protein [16] but are considered to also be important for binding to SARS-2-S based on data from the crystal structure of the ACE2 and SARS-2-S complex [17] (Figure 1).", "The amino acid positions corresponding to the selected SNPs were distantly mapped from the region previously reported to be important for binding to the SARS-CoV S protein [16] but are considered to also be important for binding to SARS-2-S based on data from the crystal structure of the ACE2 and SARS-2-S complex [17] (Figure 1)."], "intents": ["methodology", "background"]}, "216072168": {"isInfluential": true, "contexts": ["These comprised S19P and K26R, reported to potentially affect ACE2 affinity toward SARS2-S [9,10], as well as N720D, which is located far from the SARS-2-S binding domain and is, therefore, expected to have little impact on SARS-2-S binding [10]; these three SNPs are common in American and Non-Finnish European populations.", "In contrast to recent reports [9,10,20,21], the cells expressing the ACE2 variants, except for ACE2(L656X), bound to rSARS-2-S1(D614G) with similar efficiency to those expressing WT ACE2.", "These included two SNPs, S19P and K26R, which are reported to potentially affect ACE2 affinity toward SARS-2-S [9,10], and another SNP, N720D, which is located far from the SARS-2-S binding domain and is, therefore, expected to have little impact on SARS-2-S binding [10].", "included two SNPs, S19P and K26R, which are reported to potentially affect ACE2 affinity toward SARS-2-S [9,10], and another SNP, N720D, which is located far from the SARS-2-S binding domain and is, therefore, expected to have little impact on SARS-2-S binding [10]."], "intents": ["result", "background"]}, "34824949": {"isInfluential": false, "contexts": ["A replication-deficient vesicular stomatitis virus (VSV)-based pseudovirus bearing SARS-2-S with the D614G mutation was generated by following a procedure similar to that previously used to generate a pseudotype recombinant VSV complemented with hepatitis C virus glycoproteins E1 and E2 [13]."], "intents": ["methodology"]}, "212407874": {"isInfluential": false, "contexts": [], "intents": []}, "27579237": {"isInfluential": false, "contexts": ["Recent reports indicate that ACE2 cleaved by ADAM17 is released into the extracellular space [24] and this soluble form of ACE2 interacts with SARS-2-S on cell-free SARS-CoV-2 virions, leading to the inhibition of viral infection [25]."], "intents": ["background"]}, "221938123": {"isInfluential": false, "contexts": ["The VSV pseudotype bearing SARS-2-S has been used widely and reproduces the cell entry process of infectious SARS-CoV-2 effectively [1,22,23]."], "intents": ["methodology"]}, "218765011": {"isInfluential": false, "contexts": ["The VSV pseudotype bearing SARS-2-S has been used widely and reproduces the cell entry process of infectious SARS-CoV-2 effectively [1,22,23]."], "intents": ["methodology"]}, "221841647": {"isInfluential": false, "contexts": [], "intents": []}, "23044160": {"isInfluential": false, "contexts": ["For example, using the FireDock web server-based protein\u2013protein interaction simulator [8], Calcagnile et al."], "intents": ["methodology"]}, "218648676": {"isInfluential": false, "contexts": ["Recent in silico studies on TMPRSS2 indicated that several TMPRSS2 SNPs potentially affect SARS-CoV-2 infectivity and contribute toward COVID-19 severity [6,7]."], "intents": ["background"]}}, "publish_time": "2021-01-01", "journal": "Viruses"}, "227181280": {"label": "SUPPORT", "evidence": [], "aliases": [], "pinfo": {"citationCount": 85, "influentialCitationCount": 8}, "ainfo": {"authors": ["6330136", "2053671380", "1490656941", "50142067", "39557776", "2128180387", "2047639240", "2089793195", "1490658449", "48362653", "2156016471", "2087014041", "2143698046", "2108111105", "2108018692", "2109036351", "14774678", "2108509156", "2117994891", "2155888002", "2057358191", "30040986", "2065088349", "123247182", "46736076", "148405783", "2152781782", "2028957301", "2093181673", "47482939", "1384187215", "1680465", "145144021", "1498051676"], "numAuthors": 34, "maxPaperCount": 193, "medianPaperCount": 12.5, "maxCitationCount": 11508, "medianCitationCount": 202.5, "maxHIndex": 48, "medianHIndex": 6.5}, "rinfo": {"220458989": {"isInfluential": false, "contexts": [], "intents": []}, "10906412": {"isInfluential": false, "contexts": [], "intents": []}, "24696013": {"isInfluential": false, "contexts": [], "intents": []}, "210957036": {"isInfluential": false, "contexts": [], "intents": []}, "220522041": {"isInfluential": false, "contexts": [], "intents": []}, "27526797": {"isInfluential": false, "contexts": [], "intents": []}, "156795": {"isInfluential": false, "contexts": [], "intents": []}, "212629481": {"isInfluential": false, "contexts": [], "intents": []}, "53178271": {"isInfluential": false, "contexts": [], "intents": []}, "216146132": {"isInfluential": false, "contexts": [], "intents": []}, "4423127": {"isInfluential": false, "contexts": [], "intents": []}, "128804": {"isInfluential": false, "contexts": [], "intents": []}, "214756052": {"isInfluential": false, "contexts": [], "intents": []}, "43205926": {"isInfluential": false, "contexts": [], "intents": []}, "21572556": {"isInfluential": false, "contexts": [], "intents": []}, "21352715": {"isInfluential": false, "contexts": [], "intents": []}, "30556886": {"isInfluential": false, "contexts": [], "intents": []}, "29493280": {"isInfluential": false, "contexts": [], "intents": []}, "11088462": {"isInfluential": false, "contexts": [], "intents": []}, "25756348": {"isInfluential": false, "contexts": [], "intents": []}, "212631502": {"isInfluential": false, "contexts": [], "intents": []}, "3379449": {"isInfluential": false, "contexts": [], "intents": []}, "219982852": {"isInfluential": false, "contexts": [], "intents": []}, "39168398": {"isInfluential": false, "contexts": [], "intents": []}, "21948673": {"isInfluential": false, "contexts": [], "intents": []}, "1012868": {"isInfluential": false, "contexts": [], "intents": []}, "24398378": {"isInfluential": false, "contexts": [], "intents": []}, "216440959": {"isInfluential": false, "contexts": [], "intents": []}, "22709339": {"isInfluential": false, "contexts": [], "intents": []}, "212729694": {"isInfluential": false, "contexts": [], "intents": []}, "220714797": {"isInfluential": false, "contexts": [], "intents": []}, "212407874": {"isInfluential": false, "contexts": [], "intents": []}, "211231385": {"isInfluential": false, "contexts": [], "intents": []}, "221478596": {"isInfluential": false, "contexts": [], "intents": []}, "21450769": {"isInfluential": false, "contexts": [], "intents": []}, "31066052": {"isInfluential": false, "contexts": [], "intents": []}, "215800986": {"isInfluential": false, "contexts": [], "intents": []}, "218647884": {"isInfluential": false, "contexts": [], "intents": []}, "219991504": {"isInfluential": false, "contexts": [], "intents": []}}, "publish_time": "2020-01-01", "journal": "Nat Metab"}, "218534865": {"label": "SUPPORT", "evidence": ["To fulfill its function, SARS-CoV-2 spike binds to its receptor human ACE2 (hACE2) through its receptor-binding domain (RBD) and is proteolytically activated by human proteases."], "aliases": [], "pinfo": {"citationCount": 1616, "influentialCitationCount": 105}, "ainfo": {"authors": ["2057079223", "50501664", "35560616", "2075337699", "47898456", "1557690080", "48004291"], "numAuthors": 7, "maxPaperCount": 71, "medianPaperCount": 15, "maxCitationCount": 15002, "medianCitationCount": 4723, "maxHIndex": 37, "medianHIndex": 11}, "rinfo": {"32239173": {"contexts": [], "isInfluential": false, "intents": []}, "5795468": {"contexts": ["Last, the cell entry process of SARS-CoV-2 can be blocked using inhibitors that target the protease activators (47)."], "isInfluential": false, "intents": ["background"]}, "2232601": {"contexts": [", high temperature, physical force, or some chemicals) (37)."], "isInfluential": false, "intents": ["background"]}, "215797835": {"contexts": ["Taken together, these findings show that furin is the PPC that preactivates SARS-CoV-2 spike (1, 2).", "T emergence and rapid spread of a novel severe acute respiratory syndrome (SARS)-like coronavirus SARS-CoV-2 is destroying global health and economy (1, 2)."], "isInfluential": false, "intents": ["background"]}, "25022748": {"contexts": [], "isInfluential": false, "intents": []}, "214726928": {"contexts": [], "isInfluential": false, "intents": []}, "32187016": {"contexts": ["These numbers dwarf the impact of the related SARS coronavirus (SARS-CoV), which caused about 8,000 infections and 800 deaths (3, 4)."], "isInfluential": false, "intents": ["background"]}, "215718969": {"contexts": [], "isInfluential": false, "intents": []}, "18154156": {"contexts": ["Moreover, to fuse membranes, SARS-CoV spike needs to be proteolytically activated at the S1/S2 boundary, such that S1 dissociates and S2 undergoes a dramatic structural change (22, 23).", "Furin was selected in our study because it is the prototypic PPC and it preactivates the entry of many other viruses, including some coronaviruses (22, 23).", "These SARS-CoV entry-activating proteases include cell surface protease TMPRSS2 and lysosomal proteases cathepsins (22, 23) (Fig."], "isInfluential": false, "intents": ["background"]}, "10743729": {"contexts": [], "isInfluential": false, "intents": []}, "20783605": {"contexts": [], "isInfluential": false, "intents": []}, "210886197": {"contexts": ["Taken together, these findings show that furin is the PPC that preactivates SARS-CoV-2 spike (1, 2).", "T emergence and rapid spread of a novel severe acute respiratory syndrome (SARS)-like coronavirus SARS-CoV-2 is destroying global health and economy (1, 2)."], "isInfluential": false, "intents": ["background"]}, "214779011": {"contexts": [], "isInfluential": false, "intents": []}, "52842001": {"contexts": ["Retroviruses pseudotyped with SARS-CoV-2 spike or SARS-CoV spike were generated in HEK293T cells, and pseudovirus entry assay was performed as previously described (48)."], "isInfluential": false, "intents": ["methodology"]}, "6221896": {"contexts": ["The second is glycan shielding, where viruses conceal critical parts of their spike proteins behind glycan clusters (as in the case of HIV, Ebola virus, and hepatitis C virus) (43)."], "isInfluential": false, "intents": ["background"]}, "22382439": {"contexts": [], "isInfluential": false, "intents": []}, "212631502": {"contexts": ["Cryo-EM studies have shown that, in SARS-CoV spike, the RBD is mostly in the standing-up state (20, 21); however, in SARS-CoV-2 spike, the RBD is mostly in the lying-down state (31, 32).", "However, although SARSCoV-2 spike contains a PPC motif at the S1/S2 boundary, it was reported that PPC cleavage of the spike protein did not enhance SARS-CoV-2 entry into cells (31), challenging the well-established concept on the role of PPC motif.", "A third study using Blitz assay showed that SARS-CoV-2 and SARS-CoV spikes have similar hACE2 binding affinities (31).", "Similar to recent studies (31, 34), we calibrated pseudovirus entry efficiency against expression levels of spikes.", "5C), which is consistent with two recent studies (31, 34).", "However, a recent study showed that furin preactivation enhances SARS-CoV-2 pseudovirus entry into BHK cells (baby hamster kidney fibroblast cells), but reduces SARS-CoV-2 pseudovirus entry into Vero cells (African green monkey kidney epithelial cells) (31).", "However, the cryo-electron microscopy (cryo-EM) structure of SARS-CoV-2 spike revealed that its RBD is mostly in the lying-down state (31, 32), a state associated with ineffective receptor binding."], "isInfluential": true, "intents": ["result", "background"]}, "20466101": {"contexts": [], "isInfluential": false, "intents": []}, "212656559": {"contexts": [], "isInfluential": false, "intents": []}, "215410037": {"contexts": ["Yet SARS-CoV-2 remains highly infectious (11, 12)."], "isInfluential": false, "intents": []}, "211215068": {"contexts": ["However, the cryo-electron microscopy (cryo-EM) structure of SARS-CoV-2 spike revealed that its RBD is mostly in the lying-down state (31, 32), a state associated with ineffective receptor binding.", "This has also been observed with furinpreactivated avian influenza viruses (32).", "Cryo-EM studies have shown that, in SARS-CoV spike, the RBD is mostly in the standing-up state (20, 21); however, in SARS-CoV-2 spike, the RBD is mostly in the lying-down state (31, 32).", "Note that the hACE2 binding affinities of SARS-CoV RBD and SARS-CoV-2 spike should not be compared directly with each other (32)."], "isInfluential": true, "intents": ["result", "background"]}, "43557739": {"contexts": ["Importantly, viruses commonly hide their RBD or other critical parts of their spike proteins from host adaptive immune responses using two main strategies (40)."], "isInfluential": false, "intents": ["background"]}, "18484660": {"contexts": ["Because neutralizing antibodies elicited by RBD vaccines may have limited access to the RBD, structure-guided engineering will be needed to significantly enhance the efficacy of RBD vaccines (45).", "The RBD is the most immunogenic region of the whole spike (15, 45)."], "isInfluential": false, "intents": ["background"]}, "24271872": {"contexts": ["The success of this approach for vaccine development, however, may be limited because the S2 subunit is less immunogenic than the RBD (15).", "The RBD is the most immunogenic region of the whole spike (15, 45).", "It is also a major target for host immune surveillance and human intervention strategies (15, 16)."], "isInfluential": false, "intents": ["background"]}, "211253784": {"contexts": [], "isInfluential": false, "intents": []}, "12205421": {"contexts": ["The RBD in coronaviruses can be in either a standing-up state, which enables receptor binding, or a lying-down state, which does not bind to the host receptors (20, 21).", "Cryo-EM studies have shown that, in SARS-CoV spike, the RBD is mostly in the standing-up state (20, 21); however, in SARS-CoV-2 spike, the RBD is mostly in the lying-down state (31, 32).", "The RBD constantly switches between a standing-up position for receptor binding and a lying-down position for immune evasion (20, 21) (Fig."], "isInfluential": false, "intents": ["background"]}, "19656301": {"contexts": [], "isInfluential": false, "intents": []}, "38336021": {"contexts": ["Moreover, to fuse membranes, SARS-CoV spike needs to be proteolytically activated at the S1/S2 boundary, such that S1 dissociates and S2 undergoes a dramatic structural change (22, 23).", "Furin was selected in our study because it is the prototypic PPC and it preactivates the entry of many other viruses, including some coronaviruses (22, 23).", "These SARS-CoV entry-activating proteases include cell surface protease TMPRSS2 and lysosomal proteases cathepsins (22, 23) (Fig."], "isInfluential": false, "intents": ["background"]}, "211022984": {"contexts": [], "isInfluential": false, "intents": []}, "10694034": {"contexts": [], "isInfluential": false, "intents": []}, "214600442": {"contexts": ["For example, some coronavirus nonstructural proteins can help evade the host innate immune responses (38, 39)."], "isInfluential": false, "intents": ["background"]}, "214734352": {"contexts": ["This result is different from our recent report that SARS-CoV-2 RBD binds to hACE2 with significantly higher affinity than SARS-CoV RBD does, which was detected using surface plasmon resonance (SPR) (30).", "Briefly, His6tagged proteins were harvested from cell culture medium, and were purified sequentially on Ni-NTA column and Superdex200 gel filtration column (GE Healthcare) as described previously (30).", "The Fc-tagged protein was purified in the same way, except that protein A column replaced Ni-NTA column (30).", "These differences enable SARS-CoV-2 RBD to have a significantly higher hACE2 binding affinity than SARSCoV RBD does (30).", "Protein pull-down assay was performed using a Dynabeads immunoprecipitation kit (Invitrogen) as previously described (30).", "This was shown in our recent study using SPR assay as well as structural and mutagenesis analyses (30).", "We recently determined the crystal structure of SARS-CoV-2 RBD complexed with hACE2, which revealed subtle but functionally important differences between SARS-CoV-2 and SARS-CoV in receptor recognition (30).", "5B), confirming our recent SPR result."], "isInfluential": false, "intents": ["methodology", "background", "result"]}, "11158308": {"contexts": [], "isInfluential": false, "intents": []}, "216196049": {"contexts": [], "isInfluential": false, "intents": []}, "213186836": {"contexts": ["For example, some coronavirus nonstructural proteins can help evade the host innate immune responses (38, 39)."], "isInfluential": false, "intents": ["background"]}, "12438123": {"contexts": [], "isInfluential": false, "intents": []}, "210946693": {"contexts": [], "isInfluential": false, "intents": []}, "212407874": {"contexts": ["It has been shown that TMPRSS2 and lysosomal proteases are both important for SARS-CoV-2 entry (33, 34)."], "isInfluential": false, "intents": ["background"]}, "214672824": {"contexts": [], "isInfluential": false, "intents": []}, "215616048": {"contexts": [], "isInfluential": false, "intents": []}, "21981428": {"contexts": [], "isInfluential": false, "intents": []}, "208076855": {"contexts": [], "isInfluential": false, "intents": []}, "210949404": {"contexts": [], "isInfluential": false, "intents": []}, "861510": {"contexts": [], "isInfluential": false, "intents": []}, "21352345": {"contexts": ["In avian influenza viruses, proprotein convertase (PPC) motif in the surface glycoprotein is a hallmark of high pathogenesis (35)."], "isInfluential": false, "intents": ["background"]}, "24503659": {"contexts": ["Coronavirus entry into host cells is an important determinant of viral infectivity and pathogenesis (13, 14).", "Protease activation of coronavirus spikes potentially leads to the final structural change of coronavirus S2 needed for membrane fusion; this process is irreversible and needs to be tightly regulated (13).", "To enter host cells, coronaviruses first bind to a cell surface receptor for viral attachment, subsequently enter endosomes, and eventually fuse viral and lysosomal membranes (13, 14) (Fig."], "isInfluential": false, "intents": ["background"]}, "767662": {"contexts": [], "isInfluential": false, "intents": []}, "4421247": {"contexts": ["Briefly, HEK293T cells were cotransfected with a plasmid carrying an Env-defective, luciferase-expressing HIV-1 genome (pNL4-3.luc.", "The second is glycan shielding, where viruses conceal critical parts of their spike proteins behind glycan clusters (as in the case of HIV, Ebola virus, and hepatitis C virus) (43).", "The first is conformational masking, where viruses conceal their RBDs in locations like canyons (as in the case of picornaviruses) (41) or recessed pockets (as in the case of HIV) (42).", "P. D. Kwong et al., HIV-1 evades antibody-mediated neutralization through confor-\nmational masking of receptor-binding sites."], "isInfluential": true, "intents": ["background"]}}, "publish_time": "2020-01-01", "journal": "Proc Natl Acad Sci U S A"}}, "alinks": {"221819877": {"doc": "214793574", "common": ["6048696", "2633265"]}}, "rlinks": {"235628341": [{"reference": "218534865", "isInfluential": false, "intent": ["background"]}]}, "elinks": [{"fdoc_id": "218534865", "fdoc_e_num": 0, "sdoc_id": "214793574", "sdoc_e_num": 1, "label": "SUPPORT"}, {"fdoc_id": "218534865", "fdoc_e_num": 0, "sdoc_id": "221819877", "sdoc_e_num": 0, "label": "SUPPORT"}, {"fdoc_id": "214793574", "fdoc_e_num": 0, "sdoc_id": "214054683", "sdoc_e_num": 0, "label": "SUPPORT"}, {"fdoc_id": "214793574", "fdoc_e_num": 1, "sdoc_id": "218534865", "sdoc_e_num": 0, "label": "SUPPORT"}, {"fdoc_id": "214793574", "fdoc_e_num": 1, "sdoc_id": "221819877", "sdoc_e_num": 0, "label": "SUPPORT"}, {"fdoc_id": "221819877", "fdoc_e_num": 0, "sdoc_id": "218534865", "sdoc_e_num": 0, "label": "SUPPORT"}, {"fdoc_id": "221819877", "fdoc_e_num": 0, "sdoc_id": "214793574", "sdoc_e_num": 1, "label": "SUPPORT"}]}
